WO2001040462A1 - Method for measuring the extent of skin aging and measurement kit - Google Patents

Method for measuring the extent of skin aging and measurement kit Download PDF

Info

Publication number
WO2001040462A1
WO2001040462A1 PCT/JP1999/006711 JP9906711W WO0140462A1 WO 2001040462 A1 WO2001040462 A1 WO 2001040462A1 JP 9906711 W JP9906711 W JP 9906711W WO 0140462 A1 WO0140462 A1 WO 0140462A1
Authority
WO
WIPO (PCT)
Prior art keywords
skin
dna
telomere
primer
sequence
Prior art date
Application number
PCT/JP1999/006711
Other languages
French (fr)
Japanese (ja)
Inventor
Ritsuo Yamashita
Yoshikazu Aman
Original Assignee
Sony Cp Laboratories Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to JP15777398A priority Critical patent/JP4013333B2/en
Application filed by Sony Cp Laboratories Inc. filed Critical Sony Cp Laboratories Inc.
Priority to PCT/JP1999/006711 priority patent/WO2001040462A1/en
Priority to AU14136/00A priority patent/AU1413600A/en
Publication of WO2001040462A1 publication Critical patent/WO2001040462A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material

Definitions

  • the present invention relates to a method for measuring the degree of skin aging. More specifically, it relates to a method for measuring the degree of skin aging by amplifying DNA extracted from skin cells, measuring the average molecular weight of the amplified product, and determining the telomer length. . Background art
  • aging In living organisms, physiological functions change with aging, usually a decline in physiological functions, that is, aging. At the individual cell level, aging occurs, which is defined as the regression of cell morphology and function, followed by cell death or growth arrest. It is thought that the cause of such an aging phenomenon is, in addition to impaired metabolism of cells, damage of intracellular DNA and reduced repair function.
  • telomere refers to a terminal region of a chromosome, which is also referred to as a telomere, and is often composed of a simple repetitive sequence. This region is essential for the stability of chromosomes in eukaryotes.
  • A11sop and colleagues used conventional PCR methods and probes to determine the effects of telomeres on primary culturing of skin cells obtained by surgery or biopsy and aging through repeated passages. Checked by law.
  • the inventors of the present invention have made intensive studies to solve the above-mentioned problems. As a result, they found a method for easily and quickly measuring telomere length using a small amount of DNA from skin tissue cells collected without pain and without leaving any trace, and completed the present invention. It is.
  • both ends of a fragment having one cohesive end and a telomere-specific 3 'protruding end obtained by treating a DNA extracted from skin epidermal debris with a restriction enzyme are converted into blunt-ended fragments by terminal modification.
  • the restriction enzyme is characterized in that it is a restriction enzyme selected from the group consisting of Hinfl, Mspl / Hpal I. and Rsal.
  • the blunt-end fragment binds a linker consisting of a double-stranded oligonucleotide having a cohesive end complementary to the cohesive end to the cohesive end, and Two single-stranded oligonucleotides containing a 5'-CCCT AA-3 'repetitive sequence complementary to the sequence of 6 to 24 bases from the 3' end of the protruding end of the fragment with an end It is characterized in that 3 to 12 base pairs of oligonucleotides are ligated, and this is used as a primer to obtain a double-stranded oligonucleotide with blunt ends at both ends using DNA polymerase. And
  • the DNA subjected to the restriction treatment may be blunt-ended using the linker and DNA polymerase, and may be a double-stranded DNA having a sequence complementary to the cohesive end and the protruding end.
  • Gonucleotides may be used as linkers to make blunt ends.
  • the sense primer and the antisense primer A mer is characterized by having a nucleotide sequence contained in each of the above two types of linkers.
  • the primer preferably has the nucleotide sequence of SEQ ID NOS: 3 and 4.
  • telomere-containing DNA fragment obtained by treating DNA extracted from skin epidermis debris with a restriction enzyme is labeled with a label selected from the group consisting of radioisotopes, fluorescent compounds and chemiluminescent compounds. This is a method for measuring the degree of skin aging detected by a telomere detection label probe.
  • the telomere-labeled probe has a nucleotide sequence represented by SEQ ID NOS: 5 to 12.
  • the telomere-labeled probe may be a 5 ′-(TTAGGG) n ⁇ 3 ′ and / or a 5 ′-(TAACCC) labeled with a label selected from the group consisting of radioisotopes, fluorescent compounds and chemiluminescent compounds.
  • Ran-3 ′ (n represents an integer of 3 to 5) is more preferable.
  • the labeled probe is complementary to 5 ′ — (TTAGGG) hurry— 3 ′ and Z or 5 ′-(TAACCC) profession-3 ′ (n represents an integer of 3 to 5) as a labeled probe.
  • a nucleotide sequence template and a restriction enzyme recognition sequence adjacent to the base sequence, primers containing the restriction enzyme recognition sequence, and [ ⁇ - 3 H] act DNA poly main hydrolase to substrates containing at least a dNTP To obtain a reaction product, and the reaction product is reacted with the restriction enzyme to obtain a reaction product.
  • the present invention also provides a kit for measuring the degree of skin aging for carrying out the above-mentioned method, comprising at least two of a device for collecting skin epidermis debris and a tube containing a DNA extraction solution. is there.
  • This kit also provides a DNA amplification kit. It may also include a tube containing the box.
  • the reaction mix for amplification of this kit consists of a PCR solution containing EGTA, an internal standard, a TS gene protein, and a primer of SEQ ID NO: 3 as the upper layer of the wax, and is described in SEQ ID NO: 4. It is characterized in that the PCR solution containing the primer is contained in the reaction vessel as the lower layer of the wax.
  • the present invention further provides a skin epidermis debris collecting instrument, wherein a rasp including a head having a style of implanting a thorn and a grip connected to the head is used as an instrument for collecting skin epidermis debris. It is a kit for measuring the degree.
  • FIG. 1 is a diagram showing a rasp of the present invention.
  • FIG. 2 is a diagram showing the structure of TRF.
  • FIG. 3 is a diagram showing a site where the skin epidermis debris is collected on the face.
  • FIG. 4 is a diagram showing the production of a labeled probe for detecting telomeres.
  • aging refers to DNA damage or cell damage induced by ultraviolet light, lipid peroxide, ischemia, etc., and the rate of cell proliferation associated with DNA replication and cell division. It refers to the decrease due to a decrease in the ability to proliferate, and includes photoaging, free radical aging, and the like.
  • the term “reduced proliferative capacity” usually refers to the number of times a cell can proliferate in the future with respect to the number of divisions (cumulative number) of cells that can be multiplied genetically.
  • skin epidermal debris or DNA extracted from skin cells is used, and these skin epidermal debris are obtained from a living body.
  • Skin epidermis debris refers to cells such as keratinocytes or a part thereof obtained by abrasion without pain, without bleeding, and without any trace on the skin surface at an arbitrary site.
  • a cell line that can be passaged in vitro and a DNA obtained from a primary cultured cell tissue obtained from an extracted biological tissue may be used. Samples obtained from these materials are hereinafter referred to as "skin epidermis debris".
  • These skin epidermis debris and the like may be obtained by any method. For example, it may be obtained by rubbing the skin surface with a rasp or a sandpaper described later, or a tissue or a part thereof obtained by a surgical operation, biopsy, or the like may be used.
  • telomer length of a minute amount of DNA since it is possible to measure the telomer length of a minute amount of DNA, skin epidermis debris and the like can be suitably used.
  • the site from which these skin debris is collected may be the face, upper arm, back, buttocks, thighs, and other various sites, but is not limited to these sites. Therefore, it is necessary to compare the length of each telomere of DNA obtained from skin collected from a part that is often exposed to sunlight, such as a face, and a part that is less exposed to sunlight, such as a buttock. This makes it possible to examine the degree of photoaging of cells.
  • Skin debris can be painful if, for example, a dedicated instrument (rasp) is used for collection. There is no bleeding and no traces can be collected.
  • rasp a dedicated instrument
  • Rasp is a device for skin epidermis having a structure as shown in Fig. 1 (a).
  • the rasp 10 includes a head 4 having a thorn 2 implanted therein and a gripper 6 connected to the head, and the head and the gripper are connected so as to be separable.
  • the zone is a fiber that is implanted in the head of a rasp to obtain skin scraps.
  • the material of the son is not particularly limited, as long as it can be used to scrape the skin so that there is no pain or bleeding and no trace remains, and the skin surface and skin pieces can be collected. From the viewpoints of cost and production cost, it is preferable to use polypropylene, polyacryl, polyethylene, aluminum, stainless steel 18-8, or the like.
  • the tip of the thorn is made of a fibrous material having a diameter of about 1 to 10 m, as shown in Fig. 1 (c), and the tip has an acute angle. This angle is a maximum of about 30 °, and if it is 0.2 to 5 °, it is suitable for collecting skin debris by rubbing the skin without pain and bleeding and leaving no trace.
  • the shape of the head of the rasp may be any shape such as a disk, an ellipsoid, a square plate, or a rectangular parallelepiped, and is not particularly limited. Due to the amount of DNA that can be collected, the size is 5 to 20 mm in diameter or 5 to 20 mm on one side in the case of a disc or square plate, and the long axis radius is 5 to 20 in the case of an elliptical disc. In the case of 2 Omm and a short axis radius of l to 5 mm, or in the case of a rectangular plate, one side is preferably about l to 5 mm x 5 to 20 mm.
  • the thickness is not particularly limited as long as it can be connected to a grip portion described later, and is preferably about 1 to 8 mm.
  • a grip that can be held by the hand is connected to the head thus formed so that it can be separated from the head.
  • the size of the gripping portion is not particularly limited as long as it can be held by hand, and specifically, a cylindrical shape having a length of 30 to 100 mm, a diameter of 2 to 8 mm, and a long axis
  • An elliptic cylinder having a radius of 5 to 20 mm and a minor axis radius of 2 to 10 mm, or a prism having a side of 3 to 15 mm can be given.
  • Such a grip may be formed separately from the head of the rasp, or may be formed integrally with the head.
  • one end of the grip portion can be fitted or screwed into a surface of the above-mentioned head where the thorn is not implanted.
  • integral molding for example, by applying an external force with tweezers or the like, an appropriate force is applied between the head and the grip so that the head can be easily separated. It is preferable to make a depth notch 8 (see Fig. 1 (b)).
  • the material used to make the rasp is not particularly limited.Polyethylene is used because it is easy to obtain, mold, and sterilize the molded product, and it is necessary to reduce the cost of manufacturing disposable rasps. Plastics such as polystyrene, polypropylene, polyacryl, and polyvinyl chloride, and metals such as aluminum, steel, and stainless steel can be suitably used.
  • rasp when made of polypropylene or aluminum, there is an advantage that the manufacturing cost of rasp is low or sterilization is easy.
  • a polypropylene made of a rectangular parallelepiped head of about 3 ⁇ 10 ⁇ 15 ⁇ 1 and a grip section of about 5 mm in diameter and about 100 mm in length (No. 1 See Figure.)
  • the head of this rasp, Thorn tip angle is about 0.8 degrees, a density of approximately 100 Bruno cm 2, so that the length from the implantation surface to the tip of about 2D1D1, uniformly implanted Good.
  • the rasp prepared as described above is packed in a sterile bag and sterilized by, for example, "irradiation.
  • the head of the rasp with skin debris attached to the tip of the son is cut off from the gripping part, for example, by pinching it with tweezers and twisting, and the head of this rasp is used with tweezers or the like. Then, transfer to an appropriately sized container containing the aqueous solution, and collect the collected skin epidermis debris.
  • the aqueous solution used here is preferably sterile water to eliminate microorganism-derived DNase, and a preservative such as sodium azide may be added as appropriate. Further, from the viewpoint of DNA recovery efficiency, it is preferable that about 0.3 to 1.6 mL of the above aqueous solution is placed in a container having a capacity of about 0.5 to 2 mL, and the skin cells are collected here.
  • the skin epithelial cell debris collected as described above can be obtained by a known method as described below. It can be crushed by a method, but is not particularly limited. For example, chemical disruption may be performed using a surfactant, alkali or enzyme, or physical disruption may be performed by freeze-thaw or sonication using a device such as ultrasonic. Alternatively, they may be crushed in combination.
  • the DNA to be extracted is less damaged, it is preferable to freeze-thaw the aqueous solution containing the above collected cells and then completely disrupt the cells using concentrated alcohol. Freezing and thawing may be performed repeatedly.
  • alkali examples include sodium hydroxide and potassium hydroxide, and these are added to the above aqueous solution to a final concentration of about 5 to 20 mM, and a vortex mixer is used. Vigorous agitation, for example, can increase DNA extraction efficiency.
  • the alkali can be prepared by adding a small amount of concentrated NaOH to a final concentration of 12 mM and stirring vigorously with a Portex mixer.
  • the rasp head in the tube should be spun down and removed with tweezers.
  • Cell breakage can be caused by freezing and thawing as described above, as well as surfactants such as lauroyl sarcosine, Triton X-100, sodium lauryl sulfate (SDS), proteinase K, and proteinase. It may be carried out by an ordinary method using a precipitant such as protease, RNase or other enzymes, sodium dodecyl sodium / isopropyl alcohol, ethanol or the like.
  • surfactants such as lauroyl sarcosine, Triton X-100, sodium lauryl sulfate (SDS), proteinase K, and proteinase. It may be carried out by an ordinary method using a precipitant such as protease, RNase or other enzymes, sodium dodecyl sodium / isopropyl alcohol, ethanol or the like.
  • mineral oils examples include light mineral oil M-5904 (manufactured by Sigma) and the like.
  • the layering amount is about 10%, which prevents evaporation of water, DNA Is preferred for stable extraction.
  • the above aqueous solution containing DNA is neutralized with a high-concentration acid or buffer.
  • a high-concentration acid or buffer examples include hydrochloric acid and the like, and examples of the buffer include a tris-hydrochloric acid buffer (pH 7.0).
  • the solution under the oil layer may be accurately drawn out with a pit.
  • the DNA from the skin cells obtained as described above may be directly subjected to the processing described below, or may be, for example, stored frozen.
  • TRF terminal restriction DNA fragment
  • a restriction enzyme selected from the group consisting of Hinfl, Mspl / HpalK and RsaI to obtain a terminal restriction DNA fragment (TRF).
  • TRF terminal restriction DNA fragment
  • a restriction enzyme selected from the group consisting of Hinfl, Mspl / HpalK and RsaI to obtain a terminal restriction DNA fragment (TRF).
  • TRF terminal restriction DNA fragment
  • Fig. 2 the term “telomere-specific 3′-protruding end” refers to a single-stranded oligonucleotide consisting of about 10 to 20 nucleotides, which is present on the 3 ′ side of TRF.
  • E represents a portion to be endfilled
  • A represents a portion having the same sequence as the sense primer
  • B represents a portion having the same sequence as the antisense primer.
  • the length of the cohesive end is 1 to 5 bases, and in most cases 4 bases.
  • the TRF having the cohesive end and the 3′-protruding end peculiar to the telomere is converted into a blunt-end fragment by an end modification method as described below.
  • a first double-stranded oligonucleotide having a cohesive end complementary to the cohesive end of the TRF is prepared as a linker, and the oligonucleotide is prepared as described above. Attached to cohesive end of TRF. Then, the other end of the TRF having the 3 'protruding end peculiar to the telomere is attached to the 5' side of the oligonucleotide nucleotide portion complementary to the sequence of 6 to 24 bases from the 3 'side of the protruding end. Oligonucleotides of 3 to base pairs of the main strand are linked as a primer, and the endfilling is carried out by a conventional method using, for example, DNA polymerase.
  • a second double-stranded oligonucleotide (linker) having blunt ends at both ends is ligated to the end-filled protruding end according to a conventional method to obtain a blunt-end fragment.
  • two double-stranded oligonucleotides having a cohesive end and a protruding end complementary to the cohesive end of the TRF obtained as described above and a telomere-specific 3 'protruding end are provided.
  • the linker consisting of the primers is ligated according to a conventional method to obtain blunt-ended fragments.
  • Two double-stranded oligonucleotides having cohesive ends and protruding ends may be simultaneously bound to both ends of the TRF, or may be bound individually.
  • the cohesive end and the protruding end of the TRF obtained as described above are used.
  • end-filling is performed to form a blunt end, and two linkers having a blunt end are linked to obtain a blunt-end fragment.
  • the two linkers used here may be bound to both ends of the TRF simultaneously or one of them.
  • the plus strand of the linker consisting of the above-described double-stranded oligonucleotide contains a sequence to which the nucleotide sequence of the primer used in the amplification step described later is bound,
  • the blunt-ended fragment can be accurately and rapidly amplified, and the detection is easy.
  • the linker used in the present invention preferably contains the sequence 5′-AGAGTT-3 ′ in the positive chain of the linker that binds to the subtelomere side,
  • SEQ ID NO: 3 More preferably, it comprises the sequence of SEQ ID NO: 3 (SEQ ID NO: 3).
  • a linker suitable for binding to the subtelomere side of DNA extracted from skin epidermis debris according to the present invention is:
  • the 5'-CCCTAA-3 which is complementary to the sequence of 6 to 24 bases from the 3 'side of the 3' protruding end peculiar to the telomere, ie, the 3 'protruding end peculiar to the telomere,
  • the linker that binds to the 5 'side (Fig. 2) of the single-stranded oligonucleotide containing the' sequence is
  • the linker to be bonded to the telomere is arranged in such a sequence, the nucleic acid to be bonded to the subtelomere is This is because a mismatch with AGAGTT of the nucleotide sequence can be prevented, so that primer-dimer artifacts can be prevented.
  • linkers that bind to the telomere side of the 3 'protruding end specific to telomeres include
  • each chain is produced by chemical synthesis, and these two synthetic oligonucleotides may be hybridized, or the synthesized plus strand and DNA polymerase may be synthesized. Enzyme synthesis may be carried out using the enzyme.
  • a linker comprising the double-stranded oligonucleotide of the present invention in accordance with the phosphoramidite method. it can.
  • the synthesized oligonucleotides were cut out of the column with alkali, and then reversed-phase high-speed using polyacrylamide gel electrophoresis containing 7 M urea or Chroma Spin-10 column (Clontech). It may be purified by liquid chromatography (HPLC).
  • the blunt-end fragment is used in a polymerase chain reaction (PCR) in a linker consisting of a double-stranded oligonucleotide used to prepare a blunt-end fragment.
  • PCR polymerase chain reaction
  • the sequences of the sense and antisense primers are included. These primers can be synthesized using a DNA synthesizer according to a conventional method.
  • Klenow fragment is allowed to act, and the above-mentioned brass is prepared by a multi-primer method (random primer method), a nick translation method, or the like. You can also combine images.
  • primer dimer artifact means that primers anneal to each other to form a dimer.
  • the synthesized primers can be obtained by a conventional method using polyacrylamide gel or reversed-phase high-performance liquid chromatography (HPLC) using Chroma spin-10 column (Clontech) as described above. Purify and use on a PC scale.
  • linkers and primers comprising double-stranded oligonucleotides used in the present invention include linkers and primers described in SEQ ID NOs: 1 and 2, respectively. it can.
  • Primers having such a nucleotide sequence do not cause primer-dimeractivities, and can efficiently and precisely form a ⁇ -type nucleotide sequence in the amplification step. Can be amplified.
  • the blunt-ended fragment obtained by the treatment as described above is converted into a template (type ⁇ ) and a TS primer 1 (sense primer 1, SEQ ID NO: 3) having the following sequence.
  • C X primer antisense primer, SEQ ID NO: 4
  • the sequence of the CX primer used in the present invention is not a sequence completely complementary to the telomere repeat sequence, but contains a base that becomes a mismatch when annealed. By including such mismatched bases, it is possible to prevent the primer dimer from being formed by annealing to the type III telomeric sequence portion, and to anneal after the second cycle of PCR. By preferentially annealing this sequence, shortening of the amplified fragment can be prevented.
  • the amplification product thus obtained is electrophoretically separated by various electrophoresis methods such as agarose gel electrophoresis and SDS-PAGE, transferred to a membrane filter, and detected with a labeled probe.
  • TACCC TAAACCC n (where m represents an integer of 2 to 6, SEQ ID NOS: 8 to 12)
  • n 2 or less, there is a problem that the binding affinity is weak, and if n is 6 or more, handling as a probe becomes difficult. Also, there is a similar problem when m is 1 or 7 or more.
  • the template used in here at a minimum, 5'- (TTAGGG) 3 - 3 ' and Z or 5'- (TAAC CC) 3 - 3 ' complementary to the nucleotide sequence adjacent to the sequences And a restriction enzyme recognition sequence.
  • "Restriction enzyme recognition sequence” And specifically, a base sequence recognized by a restriction enzyme selected from Hinfl, Mspl / Hpa11 and RsaI.
  • the primer also contains a base sequence recognized by the above restriction enzyme.
  • the above template is allowed to act primers and [shed one 3 H] to a substrate consisting of dNTP and DNA polymerase ra one zero under normal conditions - is possible to get a reaction product containing [a 3 H] dNTP it can.
  • a probe with a high labeling rate can be obtained (for example, the method of Harley et al. (Harley CB et al., Nature 345: 458-460 (1999)). 1990); Vaz iri H. et al, EMBO J. 16: 6018-6033 (1997); Kruk PA et al., BBRC 224: 487-492 (1996))).
  • the term “probe having a high labeling rate” means a probe having a radioactivity of about 0.5 to 9 ⁇ 10 7 cpm / pmol when a radioisotope is used as a label. .
  • a fluorescent compound is used as a label or a chemiluminescent compound is used as a label, two or more sites are labeled instead of a single site such as a conventional 5 'end label, A probe whose fluorescence intensity or luminescence intensity is high.
  • Examples of the labeling compound used in the present invention include the following, but are not limited thereto.
  • radioactive labels include the following, but are not limited thereto.
  • Non-radioactive labels include fluorescent compounds such as fluorescein isothiosinate (FITC) and red tetramethylrhodamine isothiocyanate (TRITC), horseradish oxidase (HRP), luciferase and the like. Chemiluminescent compounds such as zeolites.
  • Labeled probes using these non-radioactive labels were prepared according to the method of Langer-Safer et al. (PR Langer-Safer, M. Levine, and DC Ward, Pro Natl. Acad. Sc USA 19: 4381-4385), and Rigby et al. It can be prepared by a method (TWI, Rigby, M. Dieckmann, C. Rhodes, and P. Berg, j. Mo1ec. Bio 1.113 .: 237-251 (1977)).
  • Use radioactively labeled nucleotides such as dNTPs or enzyme-labeled nucleotides such as horseradish peroxidase-labeled nucleotides and luciferase-labeled nucleotides. And are preferred for detecting small amounts of DNA from skin epidermis debris with high sensitivity.
  • a fluorescent probe When a fluorescent probe is used among these labeled probes, detection with higher sensitivity can be achieved by adding a sensitizer.
  • a sensitizer For example, when using a biotin-labeled dCTP, streptavidin-conjugated horseradish peroxidase (HRP) is bound to a labeled probe, and then the fluorescence intensity is increased by using hydrogen peroxide and a sensitizer. Increase.
  • HRP horseradish peroxidase
  • fluorescein-tyramide manufactured by NEN Life Science Products
  • piotin piotin
  • phlorestin manufactured by Molecular Probe
  • a non-radioactive labeled probe such as the above-mentioned biotin-labeled dCTP, digoxigenin-labeled dUTP, etc. enables operation outside the radiological safety management facility, and facilitates the measurement of skin aging.
  • the specific activity is several times higher than that of ⁇ 3 X 10 6 cpm / pmo 1, 2-7 X 10 7 cpm / pniol, so the telomere length can be accurately measured with DNA extracted from a small amount of skin epidermis debris can do.
  • [ 3 H] labels has the added advantage of being highly safe for researchers using them.
  • DNA is extracted from skin epidermal debris as described above, treated with a desired restriction enzyme, and blunt-ended by terminal modification.
  • a linker consisting of a double-stranded oligonucleotide containing the desired sequence is bound to this, and an amplification product partially containing the entire sequence of the letter is obtained by PCR.
  • the amplified product is electrophoretically separated, transferred to a membrane filter, and bound to the labeled probe prepared as described above, to obtain an electropherogram.
  • the obtained electropherogram is taken into an image analyzer such as Molecular Imager (manufactured by Bio Rad), and when a fluorescently labeled probe is used, the mass center of the band emitting fluorescence is determined.
  • the weighted average of the DNA length is called the mass center.
  • the mass center 1 calculates based on the following equation (1) based on the molecular weight of the marker DNA that has been subjected to the electric swim at the same time.
  • MC av represents the mass center
  • MW is the DNA length obtained from the marker DNA that was simultaneously electrophoresed.
  • FI indicates the fluorescence intensity, and I indicates the position of the band.
  • the average telomere length can be determined as the average soil standard deviation (kb), and the aging degree of the skin can be known from this value.
  • the skin collection site is selected as follows.
  • the skin is to be collected on the face, wash the area around ⁇ with stone ⁇ and rinse with water.
  • the area around ⁇ was wiped with a cotton cottage further containing rubbing alcohol (about 70%).
  • the skin was collected on a site other than the face, as in the case of the face, the skin was washed with stone, rinsed with water, and similarly wiped with alcohol.
  • a rash was applied to the skin collection site determined in (2) above, and the same site was rubbed several times lightly to collect skin epidermis debris. 1.3 mL of sterilized water (0.1% azide-containing MilliQ ultrapure water) was added to prepare the collected skin epidermis debris. did. The head and handle of the rasp, whose skin was scraped off as described above, were cut off, and the head was pinched with the attached tweezers, placed in this Etbendorf tube, and sealed.
  • the eppendorf tube containing the skin epidermal debris was frozen and thawed by immersing it in liquid nitrogen and then thawing it in warm water twice. Next, a small amount of concentrated NaOH was added to a final concentration of 12 mM, and the cells were disrupted by vigorous stirring with a Portex mixer. After this crushing, the head of the rasp was removed from the tube.
  • the gel was stained with 2 g / mL ethidium bromide, and each photographed on a UV transilluminator (VILBER LOURMAT TF-40M).
  • the collected samples were measured for the amount of keratinocytes and the amount of DNA.
  • the amount of keratinocytes was measured with a Coulter particle size counter, and an average of 1.5 to 6 ⁇ 10 6 cells was obtained from lmg of skin tissue. Variations in this range from test sample to sample do not affect telomere length measurements.
  • Hoechst 33258 as a DNA binding indicator and measuring with a fluorescent plate reader (Millipore), 3.2-9.6 g of DNA was obtained.
  • the reaction was carried out at 37 * C for 3 to 4 hours and subjected to electrophoresis. Samples that did not undergo electrophoresis immediately after the reaction were stored at 1:20.
  • Agarose (TYPE I, manufactured by Sigma) gel was prepared so that the bridge portion had a gel concentration of 1%> the pet portion was 0.8% (Marisol KS-8405, 20cm x 14cm).
  • XBoyer buffer 50 mM Tris-HC1 (H8.0) containing 20 mM sodium acetate, 2 mM EDTA, 18 mM NaC1 was used as the electrophoresis buffer. did.
  • lkb DNA Ladder (GIBC0 BRL) adjusted to 0.5 g / lane and ⁇ DNA Hind 111 digest (NIPPON GENE) adjusted to 0.3 Mg / lane were used.
  • a sample to which 3 L of each of a marker and a loading buffer had been added was ablated on a 0.8% agarose gel prepared as described above, pulled in at 85 volts, and then electrophoresed at 35 volts.
  • the agarose gel was cut out, stained with a 2 / ig / mL ethidium mouth tip for 15 minutes, placed on a UV transilluminator, and photographed with a scale.
  • the gel was immersed in 0.25N HC1 and shaken at room temperature for 15 minutes, and then washed twice with distilled water. Next, the gel was immersed in a denaturing solution containing 0.2 M NaOH and 0.6 M NaCl, shaken at room temperature for 25 minutes, and then washed three times with distilled water.
  • This gel is immersed in a neutralization solution (0.2 M Tris-HC1 (pH 7.4) containing 0.6 M NaC1), shaken at room temperature for 30 minutes, and lightly once with distilled water. Washed. Thereafter, the plate was immersed again in the NeiHlazion ion solution and shaken at room temperature for 30 minutes.
  • a neutralization solution 0.2 M Tris-HC1 (pH 7.4) containing 0.6 M NaC1
  • the gel was used. Schleicher & Schuel), 3MM filter paper immersed in 6 XSSC, paper husk, glass plate, and weight (2kg) were placed in this order and subjected to ⁇ -blotting.
  • the membrane filter was immersed in 3X SSC, lightly drained, and the position of the well was marked on the UV transilluminator.
  • the hybridization filter (IX Denhardt's solution, 1 M NaCK 50 mM Tris-HCU 1 OmM EDTA, 0.1% SDS, containing 50 g / mL denatured salmon sperm DNA), shaken at 65 for 3-4 hours, and completed prehybridization with the above probe.
  • the sample filter After the prehybridization is completed, put the sample filter in a shielded bag, and add the labeled probe and 1 / z L of denatured salmon sperm DNA (10 mg / mL) to the hybridization buffer. 2 mL was added and sealed to prevent bubbles from entering.
  • the filter was immersed in a washing buffer (4 ⁇ SSC, 0.1% SDS) and shaken at 55 for 15 minutes. After repeating this operation four times, the filter is well drained and covered with a Saran wrap. An X green film (Scientific Imaging Film, manufactured by Kodak) is placed in a cassette with an intensifying screen. ), And performed a default radiography at 180.
  • the position of the developed film and the filter was aligned, and the position of the jewel was marked by magic. Since the TRF appeared on the smear, the peak of the smear density was detected with a densitometer (Ultra Scan XL Laser Densitometer, manufactured by Pharmacia). The distance from the peak to the peak was defined as the mobility, and the length of the TRF was determined from a calibration curve created from the mobility and the marker.
  • a densitometer Ultra Scan XL Laser Densitometer, manufactured by Pharmacia
  • a linker consisting of a double-stranded oligonucleotide (SEQ ID NOS: 1 and 2) used to obtain a blunt-ended fragment was obtained by the phosphoramidite method using a DNA synthesizer (Pharmacia Biotech). Synthesized. That is, the amidite, which is a reaction substrate, is bound to the 3 'end of the nucleotide immobilized on the column, the unreacted substrate is removed, and the functional group is masked. After removal, the amidite was bonded again and the above procedure was repeated to synthesize. Oligonucleotides synthesized by the alkali treatment were excised from the column, deprotected, purified by reverse phase HPLC, and used as linkers in the following examples. Fractions were collected.
  • TS primer subtelomer primer, SEQ ID NO: 3
  • CX primer telomer primer, SEQ ID NO: 4
  • the (TTAGGG) 4 probe synthesized in the same manner was treated with formaldehyde as a cross-linking agent (bifunctional reagent), and labeled with alkaline phosphatase (AP) directly bound chemically. AlkPhos Direct (Pharmacia) was used for this labeling.
  • Example 3 (1) The TRF obtained in Example 3 (1) was fractionated by agarose gel electrophoresis as shown in Example 3 (2).
  • a marker a lkb DNA ladder (manufactured by BioRad) was used.
  • the gel electrophoresed as described above was transferred to a nitrocellulose membrane filter (OPTITRAN BA-S, manufactured by Schleider Schuel) using a transplotter (BioRad).
  • the biotin-labeled probe was prepared by adding 0.3 g / mL of biotin-labeled dCTP (Pharmacia Biotech) and dNTP and reacting with 0.1 g / mL of Klenow fragment (Takara Shuzo). Then, it was obtained by cutting with the restriction enzyme Smal.
  • the DNA obtained from the skin epidermis debris obtained in Example 1 was treated with Hinfl (Takara Shuzo) at 37 for 3 to 4 hours to obtain a DNA fragment having cohesive ends and protruding ends.
  • Hinfl Takara Shuzo
  • the following sequence is added to the subtelomere side of the DNA fragment (TRF) having the cohesive end and the protruding end obtained in (1) above.
  • Linker S having 3 ′ TTAGGCAGCTCGTCTCAAGTGA 5 ′ was bound (see FIG. 2).
  • linker T contains the base sequence of the primer for the PCR amplification step described later.
  • the DNA was ligated using DNA Ligation Kit ver. 1 (Takara Shuzo).
  • a TRF sample having blunt ends at both ends is placed in a microtube, and is incubated using DNA Ligation Kit ver. 1 (Takara Shuzo) according to a conventional method. Then, 4 volumes of ice-cold ethanol was added for precipitation to separate blunt-ended fragments.
  • the TS primer sense primer, SEQ ID NO: 3
  • the CX primer antisense primer synthesized in (112) of Example 4
  • PCR was carried out in a PCR mixture having the following composition on a Thermal Cycler PC-800 (manufactured by Astec).
  • the CX primer was isolated at the bottom of the tube by a wax, and the reaction mix containing other components was overlaid thereon. The total volume of this reaction mix was 80 L.
  • PCR was performed for 32 cycles, each cycle consisting of 94 40 sec / 50 40 sec / U ° C 50 sec.
  • the amplification product amplified in (3) above was treated, and TRF obtained from skin-derived DNA was fractionated by agarose gel electrophoresis.
  • TRF obtained from skin-derived DNA was fractionated by agarose gel electrophoresis.
  • 1 kb DNA ladder manufactured by BioRad was used.
  • telomer-containing DNA fragment and the like electrophoresed in Example 3 were transferred to a nitrocellulose membrane filter (OPTITRANBA-S, manufactured by Schleicher & Schuel) using a gel trans- blotter (manufactured by BioRad).
  • the filter was bound with a radiolabeled probe of 0.
  • MC av represents the mass center
  • MW is a DNA length to determine Ri by Ma one car DNA was subjected to electrophoresis at the same time.
  • FI represents the fluorescence intensity
  • I represents the position of the band.
  • telomere length is shown in Table 1 as the average value of TRF soil standard deviation (kb).
  • the average telomere length of any part becomes shorter as the age increases. I was Except for the average telomere length on the ⁇ bone apex, the standard deviation (SD) of the average telomere length increased in proportion to age. In addition, the reduction in mean telomere length on the apex of the tibia was the greatest, but the increase in SD was small. The shortening of the hip telomeres was the slowest. Looking further at the average telomere length, It was the buttocks of the face except for the top.
  • SD standard deviation
  • telomere shortening on the bone crest there is little variation in telomere shortening on the bone crest, and it can be used as a good index of skin aging by selecting a specific part.
  • the average telomere length of the buttocks can be a good criterion for measuring the age of the skin with age of the same individual.
  • telomeres were prepared as follows. Primer for telomere DNA synthesis that can be cleaved from the telomere by a restriction enzyme at a later step without 5 'end labeling
  • the reaction was performed at 10 for 60 minutes.
  • the labeled probe for telomere detection used in the subsequent step can be PCR-amplified (see Fig. 4).
  • 13 represents the oligonucleotide of SEQ ID NO: 13
  • 14 represents the oligonucleotide of SEQ ID NO: 14.
  • Smal and Hindlll represent the restriction enzyme cleavage sites and their recognition sites.
  • the labeled product was purified using a gel filtration column, Quick Spin Column Sephade x G-25 (manufactured by Boehringer Mannheim), and 10 mM tris buffer (pH 8.0) -20 mM KC1.
  • a restriction enzyme SmaI (manufactured by Takara Shuzo) was added to 10 mM Tris buffer (PH8.0) —2 OmM KC1 to 6 units of ZlOw L, and reacted at 30 ⁇ : for 40 minutes.
  • This digestion product was further purified using a Chroma Spin-10 column (Clontech) and polyacrylamide gel electrophoresis in the same manner as described above, and was further digested with the restriction enzyme Hindlll (Takara Shuzo). After digestion, the digestion product was purified in the same manner in the presence of 7 M urea.
  • the radiolabeled probe purified in this way was measured by a liquid scintillation counter, and the radioactivity ratio was 2 to 7 ⁇ 10 7 cpmZpmol. Activity was obtained.
  • This value was at least 6 times, and at most 20 times more than the specific activity of 1-3 ⁇ 10 6 of the conventional end-labeled probe with [ ⁇ - 32 P] dATP. Therefore, the use of this radiolabeled probe can reduce the amount of TRF to be subjected to agarose gel electrophoresis to 1/6 to 1/20 that of a conventional probe. Therefore, it is useful for measuring the degree of skin aging without leaving any trace, such as for facial skin, or when only a very small amount of skin epidermis is obtained.
  • the degree of skin aging can be measured quickly and accurately using a small amount of DNA.
  • the use of a radioactive label or the use of a small amount of a radioactive label allows rapid, safe and highly sensitive measurement of skin aging.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Surgical Instruments (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

A method for measuring the extent of skin aging which involves: the step of blunt-ending a fragment (TRF), which is obtained by treating a DNA extracted from an epidermal piece with a restriction enzyme and has a sticky end and a telomere-characteristic 3'-cohesive end, at both ends by terminal modification; the step of attaching linkers to both ends of the blunt-ended fragment followed by amplification by PCR; and the step of separating by electrophoresis the thus obtained amplification product which contains at least the whole telomere sequence in its part and detecting the average telomere length based on the distribution by using a labeled probe. By using this method, the extent of skin aging can be quickly and accurately measured with the use of a small amount of DNA.

Description

明 細 書 皮膚の老化度の測定方法および測定用キッ ト 技術分野  Description Method for measuring skin aging degree and kit for measurement
本発明は、 皮膚の老化度の測定方法に関する。 よ り詳細には、 皮膚細 胞から抽出 した D N Aを増幅させ、 増幅産物の平均分子量を測定し、 テ ロ メ ァ長を求める こ と によっ て、 皮膚の老化度を測定する方法に関す る。 背景技術  The present invention relates to a method for measuring the degree of skin aging. More specifically, it relates to a method for measuring the degree of skin aging by amplifying DNA extracted from skin cells, measuring the average molecular weight of the amplified product, and determining the telomer length. . Background art
生物では、 加齢に伴っ て生理的機能の変化、 通常は生理的機能の低 下、 すなわち老化が起こ る。 個々 の細胞レベルにおいても、 細胞の形 質、 機能の退行とそれに続く細胞死あるいは増殖停止が起こるまでの過 程と定義される老化が起こる。 こ う した老化現象の原因は、 細胞の代謝 障害等の他に、 細胞内 D N Aの傷害と修復機能の低下などが一因である と考えられている。  In living organisms, physiological functions change with aging, usually a decline in physiological functions, that is, aging. At the individual cell level, aging occurs, which is defined as the regression of cell morphology and function, followed by cell death or growth arrest. It is thought that the cause of such an aging phenomenon is, in addition to impaired metabolism of cells, damage of intracellular DNA and reduced repair function.
このような細胞の老化については、 すでにいく つかの知見が得られて いる。 すなわち、 Goldsteinの総説では、 ヒ ト二倍体繊維芽細胞において は、 細胞周期の G1ZS境界の停止が起こるために、 複製による老化、 すな わち分裂加齢が速いことが報告されている (S. Goldstein, Science, 24 9:1129- 1132 ( 1990) ) 。 また、 異なるヒ トの ドナーから得られたヒ トの 繊維芽細胞を in vitroで培養できる株として樹立して増殖させると、 細 胞の継代を重ねたときにテロメァが短く なり 、 この短縮が細胞の寿命と 関連する こ とも報告されている (R. C. Al lsop, et al. , Pro Natl. Aca d. Sci. USA, 89 : 10114 - 10118 ( 1992) ) 。 Some information has already been obtained on such cell aging. In other words, Goldstein's review reports that in human diploid fibroblasts, the G1ZS boundary of the cell cycle is arrested, so that aging by replication, that is, mitotic aging, is rapid ( S. Goldstein, Science, 24 9: 1129-1132 (1990)). Also, if human fibroblasts obtained from different human donors are established and grown as strains that can be cultured in vitro, telomeres become shorter when cells are passaged repeatedly, and this shortening is reduced. Cell lifespan Related studies have also been reported (RC Allsop, et al., Pro Natl. Acad. Sci. USA, 89: 10114-10118 (1992)).
こ こで、 テロ メァとは、 末端小粒ともいわれる染色体の末端領域をい レ 多く の場合には単純な反復配列からなる。 真核生物の染色体の安定 性に必須の領域である。  Here, a telomere refers to a terminal region of a chromosome, which is also referred to as a telomere, and is often composed of a simple repetitive sequence. This region is essential for the stability of chromosomes in eukaryotes.
したがってテロ メァ長から老化度を推定できると考えられるが、 この ようなテロメァ長を、 簡便かつ迅速に測定する こ とができる方法はこれ まで知られていない。  Therefore, it is thought that the degree of aging can be estimated from the telomer length. However, a method that can easily and quickly measure such telomer length has not been known.
A 11 s opらは、 外科手術やバイオプシーによって得られた皮膚細胞を初 代培養し、 継代を繰り返して老化させたときに、 テロメァにどのような 影響が現れるかを通常の P C R法およびプローブ法によっ て調べてい る。  A11sop and colleagues used conventional PCR methods and probes to determine the effects of telomeres on primary culturing of skin cells obtained by surgery or biopsy and aging through repeated passages. Checked by law.
具体的には、 Al ls opらは、 細胞の継代を繰り返した後に、 D N Aを抽 出して制限酵素で消化し、 Matherらの方法を改変した方法で放射性同位 体 ( R I ) 標識プローブをハイブリ ダィ ズさせ、 X A R—フィ ルムを 1~ 2日間感光させた後にデンシ トメ ト リーでオー トラジオグラムを検出する 方法を採用 している。 この方法では、 かなり の量の D N Aを必要と し、 また、 標識として R I を使用するために時間と手間がかかる。  Specifically, Alsop et al., After repeated cell passages, extracted DNA, digested it with restriction enzymes, and hybridized a radioisotope (RI) -labeled probe with a modified method of Mather et al. The X-ray film is exposed to light for 1 to 2 days, and the autoradiogram is detected by densitometry. This method requires a significant amount of DNA, and is time-consuming and tedious to use RI as a label.
したがって、 少量の D N Aを使用 してテロメァ長を短時間のう ちに正 確に知る こ とができる方法を確立し、 老化とテロメァ長との関連を明確 にすることに対する要請がある。 発明の開示  Therefore, there is a need to establish a method of accurately knowing the telomere length in a short time using a small amount of DNA, and to clarify the relationship between aging and telomere length. Disclosure of the invention
本発明の発明者 ら は、 上記の課題を解決すべく 鋭意研究を進めた結 果、 痛みもなく 、 痕跡も残らないよう に採取した微量の皮膚組織細胞か らの D N Aを用いて、 テロメァ長を簡易かつ迅速に測定する ことができ る方法を見出し、 本発明を完成したものである。 The inventors of the present invention have made intensive studies to solve the above-mentioned problems. As a result, they found a method for easily and quickly measuring telomere length using a small amount of DNA from skin tissue cells collected without pain and without leaving any trace, and completed the present invention. It is.
すなわち、 本発明は、 皮膚表皮屑片から抽出した D N Aを制限酵素処 理して得た 1つの付着末端とテロメァ特有 3'突出末端とを有する断片の両 末端を末端修飾によって平滑末端断片とする工程と、 前記平滑末端断片 の両端に リ ンカーを結合させた後に P C Rで増幅する工程と、 こ こで得 られた少なく ともテロ メァ全配列を一部に含む増幅産物を泳動分離しそ の分布から平均テロ メァ長を標識プローブで検出する工程とを備える、 皮廣の老化度の測定方法である。  That is, in the present invention, both ends of a fragment having one cohesive end and a telomere-specific 3 'protruding end obtained by treating a DNA extracted from skin epidermal debris with a restriction enzyme are converted into blunt-ended fragments by terminal modification. A step of binding a linker to both ends of the blunt-ended fragment, followed by amplification by PCR, and electrophoretically separating the amplification product obtained at least partially containing the entire telomere sequence from the distribution. Detecting the average telomere length with a labeled probe.
ここで、 上記制限酵素は、 Hinfl、 Mspl/Hpal I. および Rsalからなる群 から選ばれる制限酵素である こ とを特徴とする。 さ らに、 上記平滑末端 断片は、 上記付着末端と相補的な付着末端を有する二本鎖オリ ゴヌ ク レ ォチ ドからなる リ ンカ一を上記付着末端と結合させ、 かつ、 上記突出末 端を有する断片の突出末端の 3'側から 6~ 24塩基の配列に相補的な 5'- CCCT AA-3'の反復配列を含む一本鎖オリ ゴヌク レオチ ド部分の 5'側に二本鎖の 3 〜 12塩基対のオリ ゴヌ ク レオチ ドを連結させ、 これをプライマ一として D N Aポリ メラ一ゼで両端が平滑末端の二本鎖オリ ゴヌ ク レオチ ド とし て得られることを特徴とする。  Here, the restriction enzyme is characterized in that it is a restriction enzyme selected from the group consisting of Hinfl, Mspl / Hpal I. and Rsal. Further, the blunt-end fragment binds a linker consisting of a double-stranded oligonucleotide having a cohesive end complementary to the cohesive end to the cohesive end, and Two single-stranded oligonucleotides containing a 5'-CCCT AA-3 'repetitive sequence complementary to the sequence of 6 to 24 bases from the 3' end of the protruding end of the fragment with an end It is characterized in that 3 to 12 base pairs of oligonucleotides are ligated, and this is used as a primer to obtain a double-stranded oligonucleotide with blunt ends at both ends using DNA polymerase. And
本発明においては、 上記制限処理した D N Aを、 前記リ ンカ一と D N Aポリ メ ラーゼとを用いて平滑末端と してもよく 、 上記付着末端および 突出末端と相補的な配列を有する二本鎖オリ ゴヌ ク レオチ ドを リ ンカ一 として用いて平滑末端としてもよい。  In the present invention, the DNA subjected to the restriction treatment may be blunt-ended using the linker and DNA polymerase, and may be a double-stranded DNA having a sequence complementary to the cohesive end and the protruding end. Gonucleotides may be used as linkers to make blunt ends.
また、 上記増幅工程で用いるセンスプライマーとアンチセンスプライ マーとは、 上記の二種の リ ンカーに各々含まれるヌ ク レオチ ド配列を有 することを特徴とする。 In addition, the sense primer and the antisense primer A mer is characterized by having a nucleotide sequence contained in each of the above two types of linkers.
具体的には、 上記プライマ一は、 配列番号 3および 4に記載のヌ ク レオ チ ド配列を有することが好適である。  Specifically, the primer preferably has the nucleotide sequence of SEQ ID NOS: 3 and 4.
本発明はまた、 皮膚表皮屑片から抽出した D N Aを制限酵素処理して 得たテロ メァ含有 D N A断片を、 放射性同位体、 蛍光化合物及び化学発 光化合物からなる群から選ばれる標識で標識されたテロ メァ検出用標識 プローブで検出する皮膚の老化度の測定方法である。  In the present invention, a telomer-containing DNA fragment obtained by treating DNA extracted from skin epidermis debris with a restriction enzyme is labeled with a label selected from the group consisting of radioisotopes, fluorescent compounds and chemiluminescent compounds. This is a method for measuring the degree of skin aging detected by a telomere detection label probe.
具体的には、 上記テロメァ標識プローブは、 配列番号 5~ 12に記載のヌ ク レオチ ド配列を有することが好適である。  Specifically, it is preferable that the telomere-labeled probe has a nucleotide sequence represented by SEQ ID NOS: 5 to 12.
上記テロ メァ標識プローブは、 放射性同位体、 蛍光化合物及び化学発 光化合物からなる群から選ばれる標識で標識された 5'- (TTAGGG)n- 3'およ び/または 5'-(TAACCC)„-3' (nは 3〜 5の整数を表す) である こ とが、 さ ら に好適である。 The telomere-labeled probe may be a 5 ′-(TTAGGG) n −3 ′ and / or a 5 ′-(TAACCC) labeled with a label selected from the group consisting of radioisotopes, fluorescent compounds and chemiluminescent compounds. „-3 ′ (n represents an integer of 3 to 5) is more preferable.
また、 上記標識プローブは、 標識プローブと しての 5'— (TTAGGG)„— 3' および Zまたは 5'- (TAACCC)„-3' (nは 3〜 5の整数を表す) と相補的な塩基 配列と前記塩基配列に隣接する制限酵素認識配列とを有するテンプレー ト、 当該制限酵素認識配列を含むプライマー、 および [ α — 3 H] dNTPを 少なく とも含有する基質に D N Aポリ メ ラーゼを作用させて反応産物を 得、 当該反応産物に当該制限酵素を作用させて得られる ことを特徴とす る。 The labeled probe is complementary to 5 ′ — (TTAGGG) „— 3 ′ and Z or 5 ′-(TAACCC)„-3 ′ (n represents an integer of 3 to 5) as a labeled probe. a nucleotide sequence template and a restriction enzyme recognition sequence adjacent to the base sequence, primers containing the restriction enzyme recognition sequence, and [α - 3 H] act DNA poly main hydrolase to substrates containing at least a dNTP To obtain a reaction product, and the reaction product is reacted with the restriction enzyme to obtain a reaction product.
本発明はまた、 皮膚表皮屑片採取用器具と、 D N A抽出用溶液とを含 むチューブとの少なく とも 2つを含み、 上述した方法を実施するための皮 膚の老化度測定用キッ トである。 このキッ トはさ らに、 D N A増幅用ミ ッ クスを含むチューブを含んでもよい。 このキッ 卜の増幅用反応ミ ッ ク スは、 E GTAと、 内部標準品と、 T S遺伝子タンパク質と、 配列番号 3のブラ イマ一を含む P C R溶液をワッ クス上層と し、 配列番号 4に記載のプライ マ一を含む P C R溶液をワ ッ クス下層と して反応容器内に含むこ とを特 徴とする。 The present invention also provides a kit for measuring the degree of skin aging for carrying out the above-mentioned method, comprising at least two of a device for collecting skin epidermis debris and a tube containing a DNA extraction solution. is there. This kit also provides a DNA amplification kit. It may also include a tube containing the box. The reaction mix for amplification of this kit consists of a PCR solution containing EGTA, an internal standard, a TS gene protein, and a primer of SEQ ID NO: 3 as the upper layer of the wax, and is described in SEQ ID NO: 4. It is characterized in that the PCR solution containing the primer is contained in the reaction vessel as the lower layer of the wax.
本発明は、 さ らに、 ソーンを植え込んだ様式の頭部と、 頭部と連結さ れた把持部とを含むラスプを皮膚表皮屑片採取用器具とする こ とを特徴 とする皮膚の老化度測定用キッ トである。 図面の簡単な説明  The present invention further provides a skin epidermis debris collecting instrument, wherein a rasp including a head having a style of implanting a thorn and a grip connected to the head is used as an instrument for collecting skin epidermis debris. It is a kit for measuring the degree. BRIEF DESCRIPTION OF THE FIGURES
第 1 図は、 本発明のラスプを表す図である。  FIG. 1 is a diagram showing a rasp of the present invention.
第 2図は、 T R Fの構造を示す図である。  FIG. 2 is a diagram showing the structure of TRF.
第 3 図は、 顔における皮膚表皮屑片の採取部位を示す図である。  FIG. 3 is a diagram showing a site where the skin epidermis debris is collected on the face.
第 4図は、 テロメァ検出用標識プローブの作製を示す図である。 発明を実施するための最良の形態  FIG. 4 is a diagram showing the production of a labeled probe for detecting telomeres. BEST MODE FOR CARRYING OUT THE INVENTION
以下に、 本発明を詳細に説明する。  Hereinafter, the present invention will be described in detail.
本明細書において 「老化」 とは、 紫外線 · 過酸化脂質 · 虚血などに よっ て誘発される D N Aの障害も し く は細胞の障害、 及び D N Aの複 製、 細胞分裂に伴う細胞増殖速度の低下、 増殖余力の低下による ものを いい、 光老化、 フ リーラジカル老化などが含まれる。  As used herein, “aging” refers to DNA damage or cell damage induced by ultraviolet light, lipid peroxide, ischemia, etc., and the rate of cell proliferation associated with DNA replication and cell division. It refers to the decrease due to a decrease in the ability to proliferate, and includes photoaging, free radical aging, and the like.
こ こで、 「増殖余力の低下」 とは、 通常、 遺伝的に定まっている細胞 の増殖可能な分裂回数 (累積回数) に対して、 ある細胞が今後増殖でき る回数をいう。 本発明では、 テロメァ長を測定するために、 皮膚表皮屑片又は皮膚細 胞から抽出した D N Aを使用するが、 これらの皮膚表皮屑片は生体から 得られた ものである。 「皮膚表皮屑片」 とは、 任意の部位の皮膚表面 を、 痛みもなく 、 出血もせず、 また、 痕跡も残らずに擦過などによ り得 た角化細胞などの細胞又はその一部をいう。 また、 本発明においては、 i n v i t r oで継代が可能な株化細胞、 及び摘出生体組織から取得した初代培 養細胞組織から得られた D N Aを使用 してもよい。 これらの材料から得 られたサンプルを、 以下、 「皮膚表皮屑片等」 という。 Here, the term “reduced proliferative capacity” usually refers to the number of times a cell can proliferate in the future with respect to the number of divisions (cumulative number) of cells that can be multiplied genetically. In the present invention, in order to measure the telomere length, skin epidermal debris or DNA extracted from skin cells is used, and these skin epidermal debris are obtained from a living body. "Skin epidermis debris" refers to cells such as keratinocytes or a part thereof obtained by abrasion without pain, without bleeding, and without any trace on the skin surface at an arbitrary site. Say. In the present invention, a cell line that can be passaged in vitro and a DNA obtained from a primary cultured cell tissue obtained from an extracted biological tissue may be used. Samples obtained from these materials are hereinafter referred to as "skin epidermis debris".
また、 これらの皮膚表皮屑片等は、 いかなる方法によって得られたも のであってもよい。 例えば、 後述するラスプやサン ドペーパーなどで皮 膚表面を擦過して得ても良く 、 また、 外科的手術やバイオプシーなどに よって得られた組織又はその一部を使用してもよい。  These skin epidermis debris and the like may be obtained by any method. For example, it may be obtained by rubbing the skin surface with a rasp or a sandpaper described later, or a tissue or a part thereof obtained by a surgical operation, biopsy, or the like may be used.
本発明においては微量の D N Aのテロメァ長を測定する こ とが可能で あるため、 皮膚表皮屑片等を好適に使用することができる。  In the present invention, since it is possible to measure the telomer length of a minute amount of DNA, skin epidermis debris and the like can be suitably used.
これらの皮膚表皮屑片等を採取する部位は、 顔、 上腕部、 背部、 臀 部、 大腿部その他の各種部位を挙げる こ とができるが、 これらの部位に 限定される ものではない。 したがって、 顔などのよう に日光に曝される ことが多い部位と、 臀部などのよう に日光に曝される こ とが少ない部位 とから採取した皮膚から得た D N Aの各テロメァ長を比較する こ とによ つて、 細胞の光老化度等を調べることが可能となる。  The site from which these skin debris is collected may be the face, upper arm, back, buttocks, thighs, and other various sites, but is not limited to these sites. Therefore, it is necessary to compare the length of each telomere of DNA obtained from skin collected from a part that is often exposed to sunlight, such as a face, and a part that is less exposed to sunlight, such as a buttock. This makes it possible to examine the degree of photoaging of cells.
また、 頰骨頂部上、 起立位または座位での目尻の鉛直線 L ,と小鼻上端 の水平線 L 2との交叉部位の皮膚等を選択 (第 3 図) すると、 美容のため の皮膚の老化度を測定する こともできる。 皮膚 Select the skin at the intersection of the vertical line L at the corner of the eye, the vertical line L at the corner of the eye in the standing or sitting position, and the horizontal line L 2 at the upper end of the nose (Fig. 3). Can also be measured.
皮膚表皮屑片は、 例えば、 採取専用の器具 (ラスプ) を用いる と、 痛 みも出血もなく 、 痕跡も残らずに採取する こ とができる。 以下に、 ラス プを用いて皮膚擦過細胞屑片を採取する場合を例に挙げて説明する。 Skin debris can be painful if, for example, a dedicated instrument (rasp) is used for collection. There is no bleeding and no traces can be collected. Hereinafter, a case where skin scraping cell debris is collected using a rasp will be described as an example.
すなわち、 ラスプは、 第 1 図 ( a ) に示すような構造を有する皮膚表 皮用の器具である。 ラスプ 10は、 ソーン 2を植え込んだ頭部 4およびこの 頭部と連結された把持部 6とからなり、 頭部と把持部とは分離し得るよう に連結されている。  That is, Rasp is a device for skin epidermis having a structure as shown in Fig. 1 (a). The rasp 10 includes a head 4 having a thorn 2 implanted therein and a gripper 6 connected to the head, and the head and the gripper are connected so as to be separable.
こ こで、 ゾーンとは、 皮膚擦過片を得るためにラスプの頭部に植え込 まれる繊維をいう。 ソ一ンの材質は、 皮膚を痛みも出血もなく 、 痕跡も 残らないよ う に擦過して皮膚表皮膚片等を採取する こ とができる もので あればよく 、 特に限定されないが、 滅菌可能である こ と及び製造コス ト の面から、 ポリ プロ ピレン、 ポリ アク リル、 ポリ エチレン、 アルミニゥ ム、 ステンレス 18-8などを使用することが好ましい。  Here, the zone is a fiber that is implanted in the head of a rasp to obtain skin scraps. The material of the son is not particularly limited, as long as it can be used to scrape the skin so that there is no pain or bleeding and no trace remains, and the skin surface and skin pieces can be collected. From the viewpoints of cost and production cost, it is preferable to use polypropylene, polyacryl, polyethylene, aluminum, stainless steel 18-8, or the like.
また、 ソーンの先端部分は、 第 1 図 ( c ) に示すように直径約 1〜 10 mの繊維状物質からなり 、 その先端は鋭角状をなしている。 この角度は最 大約 30° であ り、 0. 2〜5° とすると、 皮膚を痛みも出血もなく 、 痕跡も 残らないよう に擦過して皮膚屑片を採取する上で好適である。  The tip of the thorn is made of a fibrous material having a diameter of about 1 to 10 m, as shown in Fig. 1 (c), and the tip has an acute angle. This angle is a maximum of about 30 °, and if it is 0.2 to 5 °, it is suitable for collecting skin debris by rubbing the skin without pain and bleeding and leaving no trace.
ラスプの頭部の形状は、 円盤状、 楕円盤状、 正方板状、 直方体など、 いかなる形状であってもよ く 、 特に限定されない。 大きさは、 採取でき る D N Aの量の関係から、 円盤状または正方板状の場合には直径が 5〜 20 mmまたは一辺が 5〜 20mm、 楕円盤状の場合には長軸半径が 5〜 2 Ommかつ短 軸半径が l〜5mm、 または長方形板状体の場合には一辺が l~5mmx 5〜 20mm 程度である ことが好ましい。  The shape of the head of the rasp may be any shape such as a disk, an ellipsoid, a square plate, or a rectangular parallelepiped, and is not particularly limited. Due to the amount of DNA that can be collected, the size is 5 to 20 mm in diameter or 5 to 20 mm on one side in the case of a disc or square plate, and the long axis radius is 5 to 20 in the case of an elliptical disc. In the case of 2 Omm and a short axis radius of l to 5 mm, or in the case of a rectangular plate, one side is preferably about l to 5 mm x 5 to 20 mm.
厚みは、 後述する把持部と結合できる程度であればよ く 、 特に限定さ れないが、 1~ 8mm程度が好ましい。 皮膚を擦過して皮膚表皮屑片を採取するために、 上記のような形状の 頭部に上述したソーンを約 25〜 2 25本 c m 2、 頭部の植え込み面からの長 さが約 1〜 5mmとなるよう に、 植え込む。 植え込みは、 当業者に公知の方 法で行えばよい。 The thickness is not particularly limited as long as it can be connected to a grip portion described later, and is preferably about 1 to 8 mm. By rubbing the skin in order to collect the skin epidermis debris, about 25-2 25 present cm 2 Thorn described above on the head of the above shape, the long saga about 1 from implantation surface of the head Implant so that it is 5mm. Implantation may be performed by a method known to those skilled in the art.
このよう に形成した頭部に、 手で持つこ とができる把持部を、 頭部と 分離し得るよう に連結する。 把持部の大きさは, 手で持つこ とができる 程度であればよ く 、 特に限定されないが、 具体的には、 長さが 30〜 1 00m m、 直径 2〜8mmの円柱状、 長軸半径が 5〜 20mmかつ短軸半径が 2 ~ 1 0mmの楕 円柱状、 または一辺 3〜 1 5mmの角柱状などのものを挙げることができる。 このような把持部は、 ラスプの頭部とは別個に成形してもよ く 、 頭部 と一体成形してもよい。 頭部と別個に成形する場合には、 例えば、 上記 の頭部のソーンを植え込んでいない面に把持部の一端をはめ込むか、 ま たは捩じ込むよう に連結する こ とができる。 また、 一体成形する場合に は、 例えば、 ピンセッ トなどで外力を加える ことによ り、 この頭部を容 易に切 り離すことができるよう に、 頭部と把持部との間に適当な深さの 切り込み 8 (第 1 図 ( b ) 参照) を入れておく ことが好ましい。  A grip that can be held by the hand is connected to the head thus formed so that it can be separated from the head. The size of the gripping portion is not particularly limited as long as it can be held by hand, and specifically, a cylindrical shape having a length of 30 to 100 mm, a diameter of 2 to 8 mm, and a long axis An elliptic cylinder having a radius of 5 to 20 mm and a minor axis radius of 2 to 10 mm, or a prism having a side of 3 to 15 mm can be given. Such a grip may be formed separately from the head of the rasp, or may be formed integrally with the head. In the case of molding separately from the head, for example, one end of the grip portion can be fitted or screwed into a surface of the above-mentioned head where the thorn is not implanted. In the case of integral molding, for example, by applying an external force with tweezers or the like, an appropriate force is applied between the head and the grip so that the head can be easily separated. It is preferable to make a depth notch 8 (see Fig. 1 (b)).
ラスプの作製に使用する材料は特に限定されないが、 入手、 成形及び 成形品の滅菌が容易である こ と、 また、 使い捨てである ラスプの製造コ ス トを抑える必要がある こ とから、 ポリ エチレン、 ポリ スチレン、 ポリ プロ ピレン、 ポリ アク リ ル、 ポリ塩化ビニルなどのプラスチック、 アル ミニゥム、 スチール、 ステンレスなどの金属を好適に使用する こ とがで さる。  The material used to make the rasp is not particularly limited.Polyethylene is used because it is easy to obtain, mold, and sterilize the molded product, and it is necessary to reduce the cost of manufacturing disposable rasps. Plastics such as polystyrene, polypropylene, polyacryl, and polyvinyl chloride, and metals such as aluminum, steel, and stainless steel can be suitably used.
特に、 ポリ プロ ピレンまたはアルミニウムなどで作製すると、 ラスプ の製造コス トが安く 、 又は滅菌が容易であるという利点がある。 上述したラスプの具体例としては、 約 3 Χ 10 Χ 15ΙΠΠ1の直方体状の頭部、 直径約 5mm、 長さ約 100mmの把持部とからなるポリ プロ ピレン製のものを 挙げる こ とができる (第 1 図参照) 。 このラスプの頭部には、 尖端角度 が約 0. 8度であるソーンを、 約 100本ノ cm2の密度で、 植え込み面から先端 までの長さが約 2D1D1となるように、 均一に植え込むとよい。 In particular, when made of polypropylene or aluminum, there is an advantage that the manufacturing cost of rasp is low or sterilization is easy. As a specific example of the above-mentioned rasp, there can be mentioned a polypropylene made of a rectangular parallelepiped head of about 3Χ10Χ15ΙΠΠ1 and a grip section of about 5 mm in diameter and about 100 mm in length (No. 1 See Figure.) The head of this rasp, Thorn tip angle is about 0.8 degrees, a density of approximately 100 Bruno cm 2, so that the length from the implantation surface to the tip of about 2D1D1, uniformly implanted Good.
上記のよ う に して作製したラスプを無菌袋に詰め、 例えば、 "線照射 などによって殺菌する。  The rasp prepared as described above is packed in a sterile bag and sterilized by, for example, "irradiation.
上記のラスプを清浄にした適当な部位に軽く 当てて、 この部位を数回 軽く擦過し、 皮膚表皮屑片を採取する。  Gently rub the above rasp onto an appropriate cleaned area and gently rub this area several times to collect skin debris.
ついで、 ソ一ンの尖端に皮膚表皮屑片がついたラスプの頭部を、 例え ば、 ピンセッ トで挟んでねじるよう にして把持部と切り離し、 このラス プの頭部をピンセッ トなどを用いて、 水溶液を入れた適当な大きさの容 器中に移し、 採取された皮膚表皮屑片を回収する。  Next, the head of the rasp with skin debris attached to the tip of the son is cut off from the gripping part, for example, by pinching it with tweezers and twisting, and the head of this rasp is used with tweezers or the like. Then, transfer to an appropriately sized container containing the aqueous solution, and collect the collected skin epidermis debris.
こ こで使用する水溶液は、 微生物由来の DNas eを排除するために殺菌水 である こ とが好ま し く 、 アジ化ナ ト リ ウムなどの防腐剤を適宜添加して もよい。 また、 D N Aの回収効率の面か ら 、 約 0. 5〜 2mL容量の容器内 に、 約 0. 3〜 1. 6mLの上記水溶液を入れて、 こ こに皮膚細胞を集める こ と が好ましい。  The aqueous solution used here is preferably sterile water to eliminate microorganism-derived DNase, and a preservative such as sodium azide may be added as appropriate. Further, from the viewpoint of DNA recovery efficiency, it is preferable that about 0.3 to 1.6 mL of the above aqueous solution is placed in a container having a capacity of about 0.5 to 2 mL, and the skin cells are collected here.
例えば、 し 5mLの蓋付きのエツペン ドルフチューブに 0. 1 %のアジ化ナ ト リ ムを含有する 1. 3mLの Mi l l iQ起純水を入れ、 ここに上記の皮膚表皮細 胞屑片を採取したラスプの頭部を入れる。 このときに使用するエツペン ドルフチューブの内径を 7mm以内とすると、 皮膚表皮屑片を効率よく集め ることができる。  For example, in a 5 mL eppendorf tube with a lid, add 1.3 mL of MilliQ purified water containing 0.1% sodium azide, and place the above skin epidermal debris here. Put the head of the collected rasp. If the inner diameter of the Eppendorf tube used at this time is within 7 mm, skin epidermis debris can be collected efficiently.
以上のよう にして集めた皮膚表皮細胞屑片は、 以下のような公知の方 法によって破砕する こ とができるが、 特に限定されるものではない。 例 えば、 界面活性剤、 アルカ リ も し く は酵素などを用いて化学的に破砕し てもよ く 、 凍結融解やウル ト ラソニッ ク等の装置を用いたソニケーショ ンなどによって物理的に破砕してもよく 、 さ らに、 これらを組み合わせ て破砕してもよい。 The skin epithelial cell debris collected as described above can be obtained by a known method as described below. It can be crushed by a method, but is not particularly limited. For example, chemical disruption may be performed using a surfactant, alkali or enzyme, or physical disruption may be performed by freeze-thaw or sonication using a device such as ultrasonic. Alternatively, they may be crushed in combination.
抽出する D N Aの損傷が少ないことから、 上記の採取細胞を含む水溶 液を凍結融解し、 ついで濃厚アルカ リ を用いて完全に破砕する こ とが好 ましい。 凍結融解は繰り返して行ってもよい。  Since the DNA to be extracted is less damaged, it is preferable to freeze-thaw the aqueous solution containing the above collected cells and then completely disrupt the cells using concentrated alcohol. Freezing and thawing may be performed repeatedly.
アルカ リ と しては水酸化ナ ト リ ウム、 水酸化カ リ ウムなどを挙げる こ とができ、 これらを最終濃度が約 5〜20mMになるよう に上記の水溶液に添 加してボルテッ クスミキサーなどによって激し く撹拌すると、 D N Aの 抽出効率を高めることができる。  Examples of the alkali include sodium hydroxide and potassium hydroxide, and these are added to the above aqueous solution to a final concentration of about 5 to 20 mM, and a vortex mixer is used. Vigorous agitation, for example, can increase DNA extraction efficiency.
細胞の破砕は、 例えば、 上述した 1. 5mLの蓋付きのエツペン ドルフチュ ーブを液体窒素と温水とに交互に迅速に浸けて、 凍結融解を 2回繰 り 返 す。 ついで、 アルカ リ を最終濃度 12mMとなるよう に濃 NaOHを少量添加し て、 ポルテッ クス ミキサーで激し く攪拌する ことによって行う こ とがで きる。 チューブ中のラスプの頭部は, ス ピンダウンしてから ピンセッ ト で取り出す。  For cell disruption, for example, immerse the above-mentioned 1.5 mL eppendorf tube with a lid alternately and rapidly in liquid nitrogen and hot water, and freeze and thaw twice. Then, the alkali can be prepared by adding a small amount of concentrated NaOH to a final concentration of 12 mM and stirring vigorously with a Portex mixer. The rasp head in the tube should be spun down and removed with tweezers.
細胞の破枠は、 上述のような凍結融解による ものの他、 ラウロイルサ ルコシネー ト、 Tri ton X- 100、 ラウリル硫酸ナ ト リ ウム(SDS)などの界面 活性剤、 プロティ ナーゼ K、 プロナ一ゼなどのプロテアーゼ、 RNaseその 他の酵素、 ョ一ダイ ドナ ト リ ウム · イ ソプロ ピルアルコール、 エタ ノー ルなどの沈殿剤を用いた通常の方法によって行ってもよい。  Cell breakage can be caused by freezing and thawing as described above, as well as surfactants such as lauroyl sarcosine, Triton X-100, sodium lauryl sulfate (SDS), proteinase K, and proteinase. It may be carried out by an ordinary method using a precipitant such as protease, RNase or other enzymes, sodium dodecyl sodium / isopropyl alcohol, ethanol or the like.
本発明において、 少ない液量で D N Aの抽出を行う場合には、 上記の よう に細胞を破砕し、 破砕片を沈殿させた後に所定の量の鉱物油を重層 すると、 この後に行う加熱操作中における水溶液の蒸発を防ぐ上で好適 である。 In the present invention, when extracting DNA with a small amount of liquid, It is preferable that a predetermined amount of mineral oil is overlaid after the cells are crushed and the crushed pieces are settled in order to prevent evaporation of the aqueous solution during the subsequent heating operation.
このような鉱物油と しては、 ライ ト ミ ネラルオイ ル M— 5904 (Sigma 製) などを挙げる こ とができ、 重層量は約 10 %程度とするこ とが、 水分 の蒸発を防ぎ、 D N Aを安定に抽出する上で好ましい。  Examples of such mineral oils include light mineral oil M-5904 (manufactured by Sigma) and the like. The layering amount is about 10%, which prevents evaporation of water, DNA Is preferred for stable extraction.
アルカ リ を用いた場合には、 上記の D N Aを含む水溶液を、 高濃度の 酸または緩衝液で中和する。 このような酸と しては、 例えば、 塩酸など を挙げる こ とができ、 緩衝液と しては、 例えば、 ト リ ス塩酸緩衝液 (pH 7.0) などを挙げることができる。  If alkaline is used, the above aqueous solution containing DNA is neutralized with a high-concentration acid or buffer. Examples of such an acid include hydrochloric acid and the like, and examples of the buffer include a tris-hydrochloric acid buffer (pH 7.0).
例えば、 1Mの ト リス塩酸緩衝液 (pH7.0) で中和した後に、 油層下の溶 液をピぺッ 卜で正確に吸い出すとよい。  For example, after neutralizing with 1 M Tris-HCl buffer (pH 7.0), the solution under the oil layer may be accurately drawn out with a pit.
以上のよう に して得た皮膚細胞からの D N Aは、 そのまま後述する処 理に供してもよく 、 また、 例えば、 凍結保存しておいてもよい。  The DNA from the skin cells obtained as described above may be directly subjected to the processing described below, or may be, for example, stored frozen.
得られた D N Aを、 Hinf l, Mspl/Hpal K および Rs a Iからなる群から 選択される制限酵素で消化し、 末端制限 D N A断片 (TRF : terminal res triction fragment) を得る。 これらの制限酵素で消化する ことによ り、 付着末端と突出末端とを有する T R F を得る こ とができる (第 2 図) 。 ここで、 「テロメァ特有 3'突出末端」 とは、 T R Fの 3'側に存在する、 約 10〜 20ヌク レオチ ドからなる一本鎖オリ ゴヌ ク レオチ ド部分をいう。 第 2 図中、 Eはエン ドフィ リ ングする部分、 Aはセンスプライマーと同一 の配列からなる部分、 Bはアンチセンスプライマーと同一の配列からな る部分をそれぞれ表す。 また、 付着末端の長さは 1〜 5塩基であり 、 多く の場合 4塩基である。 本発明においては形成される制限末端の塩基配列から H i n Πで消化する こ とが好ま しい。 しかし、 経時的にテロメァ長を調べる必要がある場合 には、 同一の採取箇所から 1回に採取できる皮膚表皮屑片の量を制限する 必要があるため、 Ms p Iで消化することが好ましい。 The obtained DNA is digested with a restriction enzyme selected from the group consisting of Hinfl, Mspl / HpalK and RsaI to obtain a terminal restriction DNA fragment (TRF). By digesting with these restriction enzymes, TRF having cohesive ends and protruding ends can be obtained (Fig. 2). Here, the term “telomere-specific 3′-protruding end” refers to a single-stranded oligonucleotide consisting of about 10 to 20 nucleotides, which is present on the 3 ′ side of TRF. In FIG. 2, E represents a portion to be endfilled, A represents a portion having the same sequence as the sense primer, and B represents a portion having the same sequence as the antisense primer. The length of the cohesive end is 1 to 5 bases, and in most cases 4 bases. In the present invention, it is preferable to digest with Hin か ら from the base sequence of the restriction terminal formed. However, when it is necessary to check the telomere length over time, it is necessary to limit the amount of skin epidermis debris that can be collected at one time from the same collection site, so that digestion with MspI is preferable.
ついで、 この付着末端とテロメァ特有 3'突出末端とを有する T R Fを以 下のような末端修飾法で平滑末端断片にする。  Then, the TRF having the cohesive end and the 3′-protruding end peculiar to the telomere is converted into a blunt-end fragment by an end modification method as described below.
第一の方法では、 この T R Fの付着末端と相補的な付着末端を有する 第一の二本鎖オリ ゴヌ ク レオチ ドをリ ンカ一と して作製し、 このオリ ゴ ヌ ク レオチ ドを上記 T R Fの付着末端に結合させる。 ついで、 上記 T R Fのテロメ ァ特有 3'突出末端を有する他方の端を、 突出末端の 3'側から 6 〜 24塩基の配列に相補的なオリ ゴヌ ク レオチ ド部分の 5'側に、 二本鎖の 3 〜 塩基対のオ リ ゴヌ ク レオチ ド をプライマ一と して連結させ、 これ を、 例えば、 D N Aポリ メ ラーゼなどを用いて常法に従ってエン ドフィ リ ングする。  In the first method, a first double-stranded oligonucleotide having a cohesive end complementary to the cohesive end of the TRF is prepared as a linker, and the oligonucleotide is prepared as described above. Attached to cohesive end of TRF. Then, the other end of the TRF having the 3 'protruding end peculiar to the telomere is attached to the 5' side of the oligonucleotide nucleotide portion complementary to the sequence of 6 to 24 bases from the 3 'side of the protruding end. Oligonucleotides of 3 to base pairs of the main strand are linked as a primer, and the endfilling is carried out by a conventional method using, for example, DNA polymerase.
このエン ドフィ リ ングした突出末端に、 両端が平滑末端となっている 第二の二本鎖オリ ゴヌ ク レオチ ド (リ ンカ一) を常法に従ってライゲー 卜させ、 平滑末端断片とする。  A second double-stranded oligonucleotide (linker) having blunt ends at both ends is ligated to the end-filled protruding end according to a conventional method to obtain a blunt-end fragment.
第二の方法では、 上記のよう にして得た T R Fの付着末端とテロメァ 特有 3'突出末端とに、 これら と相補的な付着末端と突出末端とを有する 2 つの二本鎖オリ ゴヌ ク レオチ ドからなる リ ンカ一を常法に従って結合さ せ、 平滑末端断片とする。 付着末端と突出末端とを有する 2つの二本鎖ォ リ ゴヌ ク レオチ ドは、 T R Fの両末端に同時に結合させてもよく 、 一方 ずつ結合させてもよい。  In the second method, two double-stranded oligonucleotides having a cohesive end and a protruding end complementary to the cohesive end of the TRF obtained as described above and a telomere-specific 3 'protruding end are provided. The linker consisting of the primers is ligated according to a conventional method to obtain blunt-ended fragments. Two double-stranded oligonucleotides having cohesive ends and protruding ends may be simultaneously bound to both ends of the TRF, or may be bound individually.
第三の方法では、 上記のよう にして得た T R Fの付着末端と突出末端 とを第一の方法の場合と同様に してェン ドフィ リ ングして平滑末端を形 成させ、 こ こに平滑末端を有する 2つのリ ンカ一を結合させて、 平滑末端 断片を得る。 こ こで使用する 2つのリ ンカ一は、 T R Fの両末端に同時に 結合させてもよく 、 一方ずつ結合させてもよい。 In the third method, the cohesive end and the protruding end of the TRF obtained as described above are used. In the same manner as in the first method, end-filling is performed to form a blunt end, and two linkers having a blunt end are linked to obtain a blunt-end fragment. The two linkers used here may be bound to both ends of the TRF simultaneously or one of them.
上記の二本鎖オリ ゴヌ ク レオチ ドからなる リ ンカ一のプラス鎖に、 後 述する増幅工程で使用するプライ マ一のヌ ク レオチ ド配列が結合する配 列を含めておく と、 これらの平滑末端断片を正確かつ迅速に増幅する こ とができ、 検出も容易となる。  If the plus strand of the linker consisting of the above-described double-stranded oligonucleotide contains a sequence to which the nucleotide sequence of the primer used in the amplification step described later is bound, The blunt-ended fragment can be accurately and rapidly amplified, and the detection is easy.
本発明において使用する リ ンカ一は、 サブテロ メ ァ側に結合する リ ン カーのプラス鎖中に 5'- AGAGTT- 3'という配列を含むことが好ま しく、  The linker used in the present invention preferably contains the sequence 5′-AGAGTT-3 ′ in the positive chain of the linker that binds to the subtelomere side,
5' AATCCGTCGAGCAGAGTTC 3'  5 'AATCCGTCGAGCAGAGTTC 3'
の配列 (配列番号 3) を含むことがさ らに好ましい。 More preferably, it comprises the sequence of SEQ ID NO: 3 (SEQ ID NO: 3).
本発明で皮膚表皮屑片から抽出 した D N Aのサブテロメァ側に結合さ せる上で好適なリ ンカ一は、  A linker suitable for binding to the subtelomere side of DNA extracted from skin epidermis debris according to the present invention is:
5' AATCCGTCGAGCAGAGTTC 3'  5 'AATCCGTCGAGCAGAGTTC 3'
3' TTAGGCAGCTCGTCTCAAGTGA 5'  3 'TTAGGCAGCTCGTCTCAAGTGA 5'
で表される付着末端を有するもの (配列番号 1) である。 (SEQ ID NO: 1).
また、 本発明においては、 テロメァ特有 3'突出末端のテロメァ側 (すな わち、 テロメァ特有 3'突出末端の 3'側から 6〜 24塩基の配列に相補的な、 5' -CCCTAA- 3'の配列を含む一本鎖オ リ ゴヌ ク レオチ ド部分の 5'側 (第 2 図) ) に結合させる リ ンカ一は、  Also, in the present invention, the 5'-CCCTAA-3, which is complementary to the sequence of 6 to 24 bases from the 3 'side of the 3' protruding end peculiar to the telomere, ie, the 3 'protruding end peculiar to the telomere, The linker that binds to the 5 'side (Fig. 2) of the single-stranded oligonucleotide containing the' sequence is
5' (CCCTAA) 3 CCCTAA 3'  5 '(CCCTAA) 3 CCCTAA 3'
を含むもの (配列番号 4) である ことが好ましい。 テロメァ側に結合させ る リ ンカーをこのよ うな配列とする と、 サブテロメァ側に結合させるヌ ク レオチ ド配列の AGAGTTとミスマッチとなるので、 プライマー · ダイマ 一アーティ ファク トを防止することができるためである。 (SEQ ID NO: 4). When the linker to be bonded to the telomere is arranged in such a sequence, the nucleic acid to be bonded to the subtelomere is This is because a mismatch with AGAGTT of the nucleotide sequence can be prevented, so that primer-dimer artifacts can be prevented.
テロメァ特有 3' 突出末端のテロメァ側に結合させる具体的なリ ンカー としては  Specific linkers that bind to the telomere side of the 3 'protruding end specific to telomeres include
5' (CCCTAA) 3 CCCTAA 3'  5 '(CCCTAA) 3 CCCTAA 3'
3' (GGGATT) a GGGATT 5'  3 '(GGGATT) a GGGATT 5'
という配列を有する平滑末端を有するもの (配列番号 2) が好ましい。 このよ うなリ ンカ一は化学合成によって各鎖を作製し、 これら二本の 合成オリ ゴヌ ク レオチ ドをハイ ブリ ダィ ズさせてもよ く 、 または、 合成 したプラス鎖と D N Aポリ メラ一ゼとを用いて酵素合成してもよい。 Having a blunt end having the sequence (SEQ ID NO: 2) is preferred. In such a linker, each chain is produced by chemical synthesis, and these two synthetic oligonucleotides may be hybridized, or the synthesized plus strand and DNA polymerase may be synthesized. Enzyme synthesis may be carried out using the enzyme.
例えば、 D N Aシンセサイザー (Pharmacia Biotech製) を用いて、 ホ スホルアミ ダイ ト (Phosphor ami di te)法に従って、 本発明の二本鎖ォリ ゴ ヌ ク レオチ ドからなる リ ンカ一を合成する こ とができる。 合成したオリ ゴヌ ク レオチ ドは、 アルカ リ によってカ ラムから切 り 出 した後に、 7 M 尿素を含むポリ アク リルアミ ドゲル電気泳動や Chroma Spin- 10 column(C lontech製)を用いた逆相高速液体ク ロマ トグラフィ ー (HPLC) などによ つて精製すればよい。  For example, using a DNA synthesizer (Pharmacia Biotech), it is possible to synthesize a linker comprising the double-stranded oligonucleotide of the present invention in accordance with the phosphoramidite method. it can. The synthesized oligonucleotides were cut out of the column with alkali, and then reversed-phase high-speed using polyacrylamide gel electrophoresis containing 7 M urea or Chroma Spin-10 column (Clontech). It may be purified by liquid chromatography (HPLC).
本発明においては、 上述したよう に平滑末端断片の作製に用いられる 二本鎖オリ ゴヌ ク レオチ ドからなる リ ンカ一の中に, この平滑末端断片 のポリ メ ラーゼ連鎖反応 ( P C R ) において使用するセンスプライマー およびアンチセンスプライマ一の配列が含まれている。 これらのプライ マーは、 常法に従い D N Aシンセサイザーを用いて合成する ことができ る。 また、 ク レノ ウ断片を作用させ、 マルチプライマー法 (ラ ンダムプ ライマ一法) 、 ニッ ク ト ラ ンス レーショ ン法などによって、 上記のブラ イマ一を合成することもできる。 In the present invention, as described above, the blunt-end fragment is used in a polymerase chain reaction (PCR) in a linker consisting of a double-stranded oligonucleotide used to prepare a blunt-end fragment. The sequences of the sense and antisense primers are included. These primers can be synthesized using a DNA synthesizer according to a conventional method. In addition, the Klenow fragment is allowed to act, and the above-mentioned brass is prepared by a multi-primer method (random primer method), a nick translation method, or the like. You can also combine images.
また、 これらのプライマーの塩基配列の長さは特に限定されないが、 合成が容易である こ と及びプライマーダイマ一アーティ フ ァ ク トを起こ さないといった面から、 約 15〜35塩基の長さであることが好ましい。 こ こで、 「プライマーダイマーアーティ フ ァク ト」 とは、 プライマー 同士が互いにァニールしてダイマ一を形成することをいう。  The length of the nucleotide sequence of these primers is not particularly limited, but is preferably about 15 to 35 nucleotides in terms of ease of synthesis and no occurrence of primer dimer artifacts. Preferably, there is. Here, “primer dimer artifact” means that primers anneal to each other to form a dimer.
合成されたプライマ一は、 上述したよう にポリ アク リ ルアミ ドゲルも しく は Chroma spin- 10 column (Clontech製) を用いた逆相高速液体ク 口マ トグラフィ ー (HPLC) などを用いて常法に従って精製し、 P C 尺に おいて使用する。  The synthesized primers can be obtained by a conventional method using polyacrylamide gel or reversed-phase high-performance liquid chromatography (HPLC) using Chroma spin-10 column (Clontech) as described above. Purify and use on a PC scale.
本発明で使用する二本鎖オリ ゴヌ ク レオチ ドからなる リ ンカ一とブラ イマ一の例と しては、 配列番号 1と 2とにそれぞれ記載されたリ ンカーと プライマーなどを挙げることができる。  Examples of linkers and primers comprising double-stranded oligonucleotides used in the present invention include linkers and primers described in SEQ ID NOs: 1 and 2, respectively. it can.
このようなヌ ク レオチ ド配列を有するプライマ一は、 プライマ一ダイ マ一ァ一ティ フ ァク トを起こさず、 増幅工程においても、 効率良く かつ 精度良く铸型となるヌ ク レオチ ド配列を増幅させることができる。  Primers having such a nucleotide sequence do not cause primer-dimeractivities, and can efficiently and precisely form a 铸 -type nucleotide sequence in the amplification step. Can be amplified.
本発明においては、 上記のよ う に処理して得た平滑末端断片をテンブ レー ト (铸型) と、 下記の配列を有する TSプライマ一 (センスプライマ 一、 配列番号 3)  In the present invention, the blunt-ended fragment obtained by the treatment as described above is converted into a template (type 铸) and a TS primer 1 (sense primer 1, SEQ ID NO: 3) having the following sequence.
5* AATCCGTCGAGCAGAGTTC 3'  5 * AATCCGTCGAGCAGAGTTC 3 '
と C Xプライマ一 (アンチセンスプライマー、 配列番号 4) And C X primer (antisense primer, SEQ ID NO: 4)
5' (CCCTAA) 3 CCCTAA 3'  5 '(CCCTAA) 3 CCCTAA 3'
とを用いて、 通常の条件に従い、 P C Rを行う こ とによ リ T R F を増幅 する。 本発明で使用する C Xプライマ一の配列は、 テロメァ反復配列と完全 に相補的な配列ではなく 、 ァニールしたときにミスマッチとなる塩基を 含んでいる。 このようなミスマッチの塩基を含むこ とによ り 、 铸型のテ ロメァ配列部分とァニールしてプライマーダイマーが形成されるのを防 ぐことができるとともに、 P C Rの 2サイ クル目以降のアニーリ ングでは 優先的にこの配列にァニールさせる こ とによ り 、 増幅断片の短縮を防止 することができる。 And amplify the TRF by performing PCR under the usual conditions. The sequence of the CX primer used in the present invention is not a sequence completely complementary to the telomere repeat sequence, but contains a base that becomes a mismatch when annealed. By including such mismatched bases, it is possible to prevent the primer dimer from being formed by annealing to the type III telomeric sequence portion, and to anneal after the second cycle of PCR. By preferentially annealing this sequence, shortening of the amplified fragment can be prevented.
こ う して得られた増幅産物は、 ァガロースゲル電気泳動、 SDS-PAGEな どの各種の電気泳動法によって泳動分離し、 メ ンブランフィ ル夕一に転 写した後に、 標識プローブで検出する。  The amplification product thus obtained is electrophoretically separated by various electrophoresis methods such as agarose gel electrophoresis and SDS-PAGE, transferred to a membrane filter, and detected with a labeled probe.
本発明においては、  In the present invention,
(TTAGGG)„ (ここで nは 3〜5の整数を表す、 配列番号 5〜7)  (TTAGGG) „(where n represents an integer of 3 to 5, SEQ ID NOS: 5 to 7)
または Or
(TAACCC) n (ここで mは 2〜 6の整数を表す、 配列番号 8〜 1 2 ) (TAACCC) n (where m represents an integer of 2 to 6, SEQ ID NOS: 8 to 12)
を含むプローブを使用することが好ま しい。 It is preferable to use a probe containing
nが 2以下では結合親和力が弱いという問題があ り 、 逆に 6以上ではプ ローブと しての取り扱いが難し く なるからである。 また、 mが 1の場合及 び 7以上の場合にも同様の問題があるからである。  If n is 2 or less, there is a problem that the binding affinity is weak, and if n is 6 or more, handling as a probe becomes difficult. Also, there is a similar problem when m is 1 or 7 or more.
(TTAGGG) n (配列番号 5〜 7 ) または(TAACCC) B (配列番号 8 ~ 1 2 ) をプロ —ブと して使用する と、 テロメァ検出の際に精度、 感度、 および操作性 が向上するという効果がある。 The use of (TTAGGG) n (SEQ ID NOS: 5-7) or (TAACCC) B (SEQ ID NOs: 8-12) as probes improves accuracy, sensitivity, and operability in telomere detection This has the effect.
こ こで使用するテンプレー トには、 少なく とも、 5'- (TTAGGG) 3- 3'およ び Zまたは 5'- (TAAC CC) 3- 3'と相補的な塩基配列、 この配列に隣接する制 限酵素認識配列とが含まれる。 「制限酵素認識配列」 とは制限酵素によ つて認識され切断される塩基配列をいい、 具体的には、 Hinf l、 Mspl/Hpa 11および Rs a Iから選ばれる制限酵素によって認識される塩基配列が好ま しい。 The template used in here, at a minimum, 5'- (TTAGGG) 3 - 3 ' and Z or 5'- (TAAC CC) 3 - 3 ' complementary to the nucleotide sequence adjacent to the sequences And a restriction enzyme recognition sequence. "Restriction enzyme recognition sequence" And specifically, a base sequence recognized by a restriction enzyme selected from Hinfl, Mspl / Hpa11 and RsaI.
プライマ一もまた、 上記の制限酵素によつて認識される塩基配列を含 む。  The primer also contains a base sequence recognized by the above restriction enzyme.
上記のテンプレー ト、 プライマーおよび [ひ 一 3 H ] dNTPからなる基質 に D N Aポリ メ ラ一ゼを通常の条件下で作用させると、 [ a — 3 H ] dNTP を含む反応産物を得る こ とができる。 この反応産物に上記の制限酵素を 通常の条件に従って作用させる と、 高標識率のプローブを得る こ とがで きる (例えば、 Harleyらの方法 (Harley C. B. et aし, Nature 345:458 -460 ( 1990); Vaz i r i H. et al, EMBO J.16:6018-6033 ( 1997) ; Kruk P. A. et al. , BBRC 224:487-492 ( 1996) ) を参照のこと) 。 The above template, is allowed to act primers and [shed one 3 H] to a substrate consisting of dNTP and DNA polymerase ra one zero under normal conditions - is possible to get a reaction product containing [a 3 H] dNTP it can. When the above-mentioned restriction enzyme is allowed to act on this reaction product under ordinary conditions, a probe with a high labeling rate can be obtained (for example, the method of Harley et al. (Harley CB et al., Nature 345: 458-460 (1999)). 1990); Vaz iri H. et al, EMBO J. 16: 6018-6033 (1997); Kruk PA et al., BBRC 224: 487-492 (1996))).
こ こで、 「高標識率のプローブ」 とは、 放射性同位体を標識と して使 用 した場合には、 約 0. 5〜 9 X 107 cpm/pmolの放射活性を有する ものをい う。 蛍光化合物を標識と して用いた場合、 または化学発光化合物を標識 と して用いた場合には、 従来の 5'末端標識のような一箇所の標識ではな く 、 二箇所以上が標識され、 蛍光強度または発光強度が高く なつている プローブをいう。 Here, the term “probe having a high labeling rate” means a probe having a radioactivity of about 0.5 to 9 × 10 7 cpm / pmol when a radioisotope is used as a label. . When a fluorescent compound is used as a label or a chemiluminescent compound is used as a label, two or more sites are labeled instead of a single site such as a conventional 5 'end label, A probe whose fluorescence intensity or luminescence intensity is high.
本発明で使用する標識化合物と しては、 以下のものを挙げる こ とがで きるが、 これらに限定されるものではない。 放射性標識と しては、  Examples of the labeling compound used in the present invention include the following, but are not limited thereto. As radioactive labels,
[ 3 H ] 、 [ 3 2 P ] も しく は [ 1 4 C ] などが挙げられる。 [3 H], [3 2 P] is also properly the like [1 4 C].
また、 非放射性標識としては、 フルォレセイ ンイ ソチオシァネー ト ( F ITC) 、 赤色系のテ ト ラメチルローダミ ンイ ソチオシァネー ト (TRITC) などの蛍光化合物、 西洋ヮサビベルォキシダ一ゼ (HRP) 、 ルシフェラ一 ゼなどの化学発光化合物を挙げることができる。 Non-radioactive labels include fluorescent compounds such as fluorescein isothiosinate (FITC) and red tetramethylrhodamine isothiocyanate (TRITC), horseradish oxidase (HRP), luciferase and the like. Chemiluminescent compounds such as zeolites.
これら非放射性標識を用いた標識プローブは、 Langer-Saferらの方法 ( P. R. Langer-Saf er, M. Levine, and D. C. Ward, Pro Nat l. Acad. Sc U. S. A. 19 : 4381 -4385) 、 Rigbyらの方法 (T. W. I. , Rigby, M. Dieck mann, C. Rhodes, and P. Berg, j . Mo 1 ec. B i o 1. 113. : 237-251 ( 1977) ) な どによって作製することができる。  Labeled probes using these non-radioactive labels were prepared according to the method of Langer-Safer et al. (PR Langer-Safer, M. Levine, and DC Ward, Pro Natl. Acad. Sc USA 19: 4381-4385), and Rigby et al. It can be prepared by a method (TWI, Rigby, M. Dieckmann, C. Rhodes, and P. Berg, j. Mo1ec. Bio 1.113 .: 237-251 (1977)).
本発明においては、 ピオチン標識 dCTP、 ジゴキシゲニン標識 dUTP、 FIT C標識 dGTP、 TRITC標識 dCTPなどの蛍光標識ヌク レオチ ド、 [ α — 3 H ] dN TP, [ r - 3 P ] dNTPも し く は [ a — 1 4 C ] dNTPなどの放射性標識ヌ ク レオチ ド、 又は西洋ヮサビペルォキシダーゼ標識ヌ ク レオチ ド、 ルシフ エラ一ゼ標識ヌ ク レオチ ドなどの酵素標識ヌ ク レオチ ドを使用する こ と が、 皮膚表皮屑片等からの少量の D N Aを高感度で検出する上で好ま し い。 In the present invention, Piochin labeled dCTP, digoxigenin-labeled dUTP, FIT C-labeled dGTP, fluorescent labels quinuclidine Reochi de such TRITC-labeled dCTP, [α - 3 H] dN TP, [r - 3 P] dNTP also rather the [ a — 14 C] Use radioactively labeled nucleotides such as dNTPs or enzyme-labeled nucleotides such as horseradish peroxidase-labeled nucleotides and luciferase-labeled nucleotides. And are preferred for detecting small amounts of DNA from skin epidermis debris with high sensitivity.
これらの標識プローブのう ち蛍光プローブを用いた場合には、 増感剤 を加える と一層高感度の検出が可能となる。 例えば、 ピオチン標識 dCTP を用いた場合には、 ス ト レブ トアビジン結合西洋ヮサビペルォキシダー ゼ (HRP) を標識プローブに結合させ、 ついで過酸化水素と增感剤とを用 いると蛍光強度が増大する。  When a fluorescent probe is used among these labeled probes, detection with higher sensitivity can be achieved by adding a sensitizer. For example, when using a biotin-labeled dCTP, streptavidin-conjugated horseradish peroxidase (HRP) is bound to a labeled probe, and then the fluorescence intensity is increased by using hydrogen peroxide and a sensitizer. Increase.
増感剤としては、 フルォレセイ ン—チラミ ド (NEN Li fe Science Prod uc ts製) 、 ピオチン、 フロ レスチン (モレキュラープローブ製) などを 好適に使用することができる。  As the sensitizer, fluorescein-tyramide (manufactured by NEN Life Science Products), piotin, phlorestin (manufactured by Molecular Probe) and the like can be suitably used.
ピオチン標識 dCTP、 ジゴキシゲニン標識 dUTPなどの上述のような非放 射性標識プローブを使用する と、 放射能安全管理施設外における操作が 可能となり、 皮膚の老化の測定を簡便に行う ことができる。 また、 本発明の放射性標識プローブは、 [ ァ 一 3 2 P ] ATPと T4ポリ ヌ ク レオチ ドキナーゼなどによって 5'末端標識された従来の標識プローブ (Harley に B. ら (前出) ) の比活性が!〜 3 X 106 cpm/pmo 1であるのに比 ベて、 比活性が 2〜7X107 cpm/pniolと数倍高いため、 少量の皮膚表皮屑片 から抽出 した D N Aで精度良く テロメァ長を測定する こ とができる。 さ らに、 [ 3 H] 標識を使用するとこれらを使用する研究者に対する安全性 も高いという利点がある。 The use of a non-radioactive labeled probe such as the above-mentioned biotin-labeled dCTP, digoxigenin-labeled dUTP, etc. enables operation outside the radiological safety management facility, and facilitates the measurement of skin aging. The ratio of radiolabeled probes of the present invention, [§ one 3 2 P] ATP and T4 polynucleotidyl click Reochi Dokinaze like the 5 'end-labeled prior labeled probe (B. et al Harley (supra)) Activity! The specific activity is several times higher than that of ~ 3 X 10 6 cpm / pmo 1, 2-7 X 10 7 cpm / pniol, so the telomere length can be accurately measured with DNA extracted from a small amount of skin epidermis debris can do. In addition, the use of [ 3 H] labels has the added advantage of being highly safe for researchers using them.
本発明においては、 皮膚表皮屑片から上述のよう に して D N Aを抽出 し、 所望の制限酵素で処理し、 末端修飾によって平滑末端とする。 こ こ に所望の配列を含有する二本鎖オリ ゴヌ ク レオチ ドからなる リ ンカ一を 結合させ、 P C Rによ リ テロメァ全配列を一部に含む増幅産物を得る。 この増幅産物を泳動分離して、 メ ンブランフィ ルタ一に転写して上述の よう に作製した標識プローブと結合させる と、 エレク ト ロフォ ログラム が得られる。  In the present invention, DNA is extracted from skin epidermal debris as described above, treated with a desired restriction enzyme, and blunt-ended by terminal modification. A linker consisting of a double-stranded oligonucleotide containing the desired sequence is bound to this, and an amplification product partially containing the entire sequence of the letter is obtained by PCR. The amplified product is electrophoretically separated, transferred to a membrane filter, and bound to the labeled probe prepared as described above, to obtain an electropherogram.
得られたエレク ト ロフォログラムを、 例えば、 Molecular Imager (Bio Rad製) などの画像解析装置に取り込み、 蛍光標識プローブを用いた場合 には、 蛍光を発しているバン ドのマスセンターを求める。 こ こで、 加重 平均した D N A長をマスセンターという。 マスセンタ一は同時に電気泳 動を行ったマーカー D N Aの分子量を基準と して、 以下の式 (1) に基づ いて算出する。  The obtained electropherogram is taken into an image analyzer such as Molecular Imager (manufactured by Bio Rad), and when a fluorescently labeled probe is used, the mass center of the band emitting fluorescence is determined. Here, the weighted average of the DNA length is called the mass center. The mass center 1 calculates based on the following equation (1) based on the molecular weight of the marker DNA that has been subjected to the electric swim at the same time.
MCa v =∑ (MWi XFI j ) Z∑ (FI i ) MC av = ∑ (MWi XFI j) Z∑ (FI i)
ここで、 MCa vはマスセンタ一を表し、 MWは同時に電気泳動を行ったマ —カー D N Aよ り求める D N A長である。 FIは蛍光強度を、 また、 I は バン ドの位置を表す。 上記の式に基づいて、 平均テロメァ長を平均値土標準備差 (k b ) と し て求めることができ、 この値から皮膚の老化度を知ることができる。 実施例 Here, MC av represents the mass center, and MW is the DNA length obtained from the marker DNA that was simultaneously electrophoresed. FI indicates the fluorescence intensity, and I indicates the position of the band. Based on the above equation, the average telomere length can be determined as the average soil standard deviation (kb), and the aging degree of the skin can be known from this value. Example
以下、 実施例によ り本発明を詳細に説明するが、 本発明はこれらに限 定されるものではない。  Hereinafter, the present invention will be described in detail with reference to Examples, but the present invention is not limited thereto.
(実施例 1 ) 皮膚の採取  (Example 1) Collection of skin
( 1 ) 採取部位の選択  (1) Selection of sampling site
皮膚の採取部位は、 以下のよう にして選択する。  The skin collection site is selected as follows.
顔の場合には、 鏡で顔を見ながら、 起立位か座位で、 目尻の鉛直線 L , と小鼻上端の水平線 L 2との交又部位の頰皮膚 (第 3 図) を選択するか、 または、 鏡を見ないで、 清潔な指による感触で頰骨頂部をさ ぐり あてて この上の皮膚を選択する。 . In the case of a face, look at the face in a mirror and select the skin (Fig. 3) at the intersection of the vertical line L at the corner of the eye and the horizontal line L 2 at the upper end of the nostril while standing or sitting. Or, without looking in the mirror, touch the top of the bone with a clean finger and select the skin above it. .
顔以外の部位には、 臀部や大腿部など日光に曝されない部位を選択す る。  For areas other than the face, select areas that are not exposed to sunlight, such as the buttocks and thighs.
( 2 ) 皮膚の採取の準備  (2) Preparation for skin collection
皮膚の採取部位が顔の場合には、 石鹼で頰の付近を充分に洗い、 水で 濯ぐ。 好ま し く は、 さ らに消毒用アルコール (約 70 % ) を含ませたコ ッ ト ンで、 頰の付近を拭いた。  If the skin is to be collected on the face, wash the area around 頰 with stone 鹼 and rinse with water. Preferably, the area around 頰 was wiped with a cotton cottage further containing rubbing alcohol (about 70%).
皮膚の採取部位が顔以外の場合も、 顔の場合と同様に、 石験で洗浄し た後に水で濯ぎ、 同様にアルコールで拭いた。  When the skin was collected on a site other than the face, as in the case of the face, the skin was washed with stone, rinsed with water, and similarly wiped with alcohol.
( 3 ) 皮膚の採取  (3) Skin sampling
上記 (2 ) で決定した皮膚の採取部位に、 ラ スプをあてて同一部位を軽 く数回擦り、 皮膚表皮屑片を採取した。 採取した皮膚表皮屑片を入れるために、 1.3mLの殺菌水 (0. 1 %ァザィ ド含有 Mi l l iQ超純水) を入れた 1. 5mLの蓋付きエツペン ドルフチューブ (内径 7mm以内) を用意した。 上記のよう に皮膚を擦り取ったラスプの頭 部と柄とを切 り離し、 頭部を付属のピンセッ トでつまんで、 このエツべ ン ドルフチューブの中に入れて密栓した。 A rash was applied to the skin collection site determined in (2) above, and the same site was rubbed several times lightly to collect skin epidermis debris. 1.3 mL of sterilized water (0.1% azide-containing MilliQ ultrapure water) was added to prepare the collected skin epidermis debris. did. The head and handle of the rasp, whose skin was scraped off as described above, were cut off, and the head was pinched with the attached tweezers, placed in this Etbendorf tube, and sealed.
(実施例 2) 採取した皮膚試料の処理 (Example 2) Processing of collected skin samples
(1) 細胞の破枠  (1) Cell frame
皮膚表皮屑片を含むエツペン ドルフチューブを、 液体窒素に浸けて凍 結し、 次に温水に浸けて融解するという凍結融解操作を 2回繰り返した。 ついで、 最終濃度が 12mMとなるよう に濃厚 NaOHを少量加えて、 ポルテツ クス · ミ キサーで激し く 攪拌して細胞の破砕を行っ た。 この破砕の後 に、 ラスプの頭部をチューブから取り出した。  The eppendorf tube containing the skin epidermal debris was frozen and thawed by immersing it in liquid nitrogen and then thawing it in warm water twice. Next, a small amount of concentrated NaOH was added to a final concentration of 12 mM, and the cells were disrupted by vigorous stirring with a Portex mixer. After this crushing, the head of the rasp was removed from the tube.
(2) 被験試料の調製  (2) Preparation of test sample
破碎物をスピンダウン してから、 ライ トミネラルオイル M- 5904 (Sigma 製) を 10%容量となるよう に重層し、 95 のヒー トブロ ッ クで 10分間加 熱した。  After spinning down the crushed material, it was overlaid with light mineral oil M-5904 (manufactured by Sigma) so as to have a 10% volume, and heated with 95 heat blocks for 10 minutes.
この後に、 1 Mの ト リ ス塩酸緩衝液 (PH7.0) を加えて試料を含む水溶 液を中和し、 オイルの下にある試料をピペッ トで正確に吸い出 して、 ェ ッペン ドルフチューブに移し、 ー 80でで凍結した。  This is followed by the addition of 1 M Tris-HCl buffer (PH 7.0) to neutralize the aqueous solution containing the sample, and the sample under the oil is accurately pipetted out and eppendorf. Transferred to tubes and frozen at -80.
一 80 :で凍結した試料を常温に戻した後に、 IsoQuick Nucleic Acid E xtract ion Kit (ORCA Research Inc. ) を用いて抽出を行った。 抽出した D N Aを TE ( ImMの EDTAを含む 10mMの Tris— HC1 (pH8.0) ) に溶解し、 4で で保存した。 D N Aの濃度測定は Mup idのミニゲル泳動槽 (コスモバイ オ製) 、 0.3 5%のァガロース (TYPE H、 和光純薬製) ゲル、 および 5%のグリ セ リ ン、 0.025%のブロモフエノールブルー (BPB) 、 0.025 %のキシレンシァ ノール FFを含むローデイ ングバッ ファーを使用 した。 1 z Lの D N A溶液 に 5 Lの TEを加えて重く した D N A試料と、 対照試料用に調製した 10 L の λ DNA(100ng/mL)とをそれぞれ別のゲルにアプライ し、 1 XTAEバッ ファ 一 (5mMの酢酸と ImMの EDTAとを含有する 40mMの Tris— HC1 (pH8.0) ) 中 で泳動させ, BPBがゲルの 2/3まで進んだところで泳動を止めた。 After the sample frozen at 80: was returned to room temperature, extraction was carried out using an IsoQuick Nucleic Acid Extraction Kit (ORCA Research Inc.). The extracted DNA was dissolved in TE (10 mM Tris-HCl (pH 8.0) containing ImM EDTA) and stored at 4. DNA concentration measurement was performed using Mupid mini gel electrophoresis tank (Cosmo Bio), 0.35% agarose (TYPE H, Wako Pure Chemical) gel, 5% glycerin, and 0.025% bromophenol blue (BPB ), A loading buffer containing 0.025% xylene FF was used. A DNA sample weighed by adding 5 L TE to 1 zL DNA solution and 10 L λ DNA (100 ng / mL) prepared for a control sample were applied to separate gels, and 1 XTAE buffer was added. Electrophoresis was performed in one (40 mM Tris-HC1 (pH 8.0) containing 5 mM acetic acid and ImM EDTA) and stopped when BPB reached 2/3 of the gel.
こ のゲルを 2 g/mLのェチジゥムブロマイ ドで染色し、 U V トランスィ ルミネーター (VILBER LOURMAT TF-40M) にのせてそれぞれ写真撮影を行 つた。  The gel was stained with 2 g / mL ethidium bromide, and each photographed on a UV transilluminator (VILBER LOURMAT TF-40M).
この写真について画像解析 (NIH Image) を行い、 対照と比較して、 D N A濃度を求めた。  Image analysis (NIH Image) was performed on this photograph, and the DNA concentration was determined in comparison with the control.
(3) 被験試料の保存  (3) Storage of test sample
採取された試料を、 角化細胞の量および D N Aの量について測定 し た。 角化細胞の量は Coulter粒度カウンターで測定し、 平均値としてなら すと皮膚組織 lmgから 1.5〜6X 106個が得られた。 被験試料ごとのこの範囲 のばらつきは、 テロメァ長の測定に影響しない。 Hoechst 33258を D N A 結合性指示薬として用い、 蛍光プレー ト リーダ一 (Mil lipore製) で測定 したところ、 3.2〜 9.6 gの D N Aが得られた。 The collected samples were measured for the amount of keratinocytes and the amount of DNA. The amount of keratinocytes was measured with a Coulter particle size counter, and an average of 1.5 to 6 × 10 6 cells was obtained from lmg of skin tissue. Variations in this range from test sample to sample do not affect telomere length measurements. Using Hoechst 33258 as a DNA binding indicator and measuring with a fluorescent plate reader (Millipore), 3.2-9.6 g of DNA was obtained.
採取された試料の数がある程度まとまるまで、 上記の D N A含有チュ —ブを一 70でで保存した。  The above DNA-containing tubes were stored at 170 until the number of samples collected was somewhat congruent.
(実施例 3) サザンブロ ッ ト法による末端制限 D N A断片 T R F長の解析 (1) 試料の調製 (Example 3) Analysis of end-restricted DNA fragment TRF length by Southern blot method (1) Sample preparation
1.5mLのチューブに の 10XHバッ フ ァー (宝酒造製) 、 2 Lの D N A 溶液、 および滅菌水を総量 19 Lとなるよう に加え、 最後に Hinfl (6U/ Z L、 宝酒造製) を加えた。  To a 1.5 mL tube, 10XH buffer (Takara Shuzo), 2 L of a DNA solution and sterilized water were added to a total volume of 19 L, and finally Hinfl (6U / ZL, Takara Shuzo) was added.
37*Cで 3~4時間反応させ、 電気泳動にかけた。 反応後直ち に電気泳動 しなかった試料については一 20 :で保存した。  The reaction was carried out at 37 * C for 3 to 4 hours and subjected to electrophoresis. Samples that did not undergo electrophoresis immediately after the reaction were stored at 1:20.
(2) ァガロースゲル電気泳動  (2) Agarose gel electrophoresis
ァガロース (TYPE I、 Sigma製) ゲルは、 ブリ ッ ジ部分のゲル濃度が 1 % > ペッ ト部分が 0.8%になるように作製した (マリ ソル KS- 8405、 20cm X 14cm) 。 泳動用バッ フ ァ一としては、 l XBoyerバッ フ ァー (20mMの酢 酸ナ 卜 リ ウム、 2mMの EDTA、 18mMの NaC 1を含む 50mMの Tr i s - HC 1 ( H8. 0) ) を使用した。  Agarose (TYPE I, manufactured by Sigma) gel was prepared so that the bridge portion had a gel concentration of 1%> the pet portion was 0.8% (Marisol KS-8405, 20cm x 14cm). XBoyer buffer (50 mM Tris-HC1 (H8.0) containing 20 mM sodium acetate, 2 mM EDTA, 18 mM NaC1) was used as the electrophoresis buffer. did.
マーカ一と しては、 0.5 g /レーンに調整した lkbの DNA Ladder (GIBC0 BRL製) と、 0.3M g/レーンに調整し λ DNA Hind 111 digest (NIPPON G ENE製) とを使用した。  As markers, lkb DNA Ladder (GIBC0 BRL) adjusted to 0.5 g / lane and λ DNA Hind 111 digest (NIPPON GENE) adjusted to 0.3 Mg / lane were used.
マーカ一とローデイ ングバッ フ ァーとを 3 Lずつ加えた試料を上記の よう に調整した 0.8%のァガロースゲルにアブライ し、 85ボル トで引き込 んだ後に、 35ボル トで泳動を行った。  A sample to which 3 L of each of a marker and a loading buffer had been added was ablated on a 0.8% agarose gel prepared as described above, pulled in at 85 volts, and then electrophoresed at 35 volts.
(3) サザン トランスファ一 、  (3) Southern transfer,
電気泳動終了後、 ァガロースゲルを切り出し、 2/i g/mLのェチジゥムブ 口マイ ドで 15分間染色し、 U V ト ラ ンスイルミネーターにのせてスケ一 ルとともに写真撮影を行った。  After completion of the electrophoresis, the agarose gel was cut out, stained with a 2 / ig / mL ethidium mouth tip for 15 minutes, placed on a UV transilluminator, and photographed with a scale.
写真撮影の後に、 ゲルを 0.25Nの HC1に浸して室温で 15分間振盪し、 つ いで蒸留水で 2回洗浄した。 ついで、 0. 2Mの NaOHと 0. 6Mの NaClとを含む変性 (Denatural i zat i o n) 溶液にゲルを浸して室温で 25分間振盪し、 その後に蒸留水で 3回洗浄 した。 After photography, the gel was immersed in 0.25N HC1 and shaken at room temperature for 15 minutes, and then washed twice with distilled water. Next, the gel was immersed in a denaturing solution containing 0.2 M NaOH and 0.6 M NaCl, shaken at room temperature for 25 minutes, and then washed three times with distilled water.
このゲルを中和 (Neutral izat ion) 溶液 ( 0.6 Mの NaC 1を含む 0. 2 Mの T ris - HC1 (pH7. 4) ) に浸して室温で 30分間振盪し、 蒸留水で軽く 1回洗 浄した。 この後、 再び NeiHral i zat ion溶液に浸して室温で 30分間振盪し た。  This gel is immersed in a neutralization solution (0.2 M Tris-HC1 (pH 7.4) containing 0.6 M NaC1), shaken at room temperature for 30 minutes, and lightly once with distilled water. Washed. Thereafter, the plate was immersed again in the NeiHlazion ion solution and shaken at room temperature for 30 minutes.
6 X SSCを満たしたプロ ッティ ング装置にセッ 卜 した 3MMろ紙上に空気が 入らないよ う に、 ゲル、 6 XSSCに渡しておいたニ ト ロセルロースメ ンブ レンフィ ル夕一 (0PTITRAN BA-S 85、 Schleicher & Schuel製) 、 6 XSSCに浸しておいた 3MMろ紙、 ペーパー夕オル、 ガラス板、 重り (2kg) の順に載せ、 ー晚ブロッテイ ングを行った。  In order to prevent air from entering the 3MM filter paper set in the plotting device filled with 6 X SSC, the gel was used. Schleicher & Schuel), 3MM filter paper immersed in 6 XSSC, paper husk, glass plate, and weight (2kg) were placed in this order and subjected to 晚 -blotting.
ブロ ッテイ ングの終了後、 メ ンブレンフィ ルターを 3 X SSCに浸し、 軽 く水分を切ってから U V ト ランスイルミ ネーター上でゥエルの位置を記 入した。  After the blotting, the membrane filter was immersed in 3X SSC, lightly drained, and the position of the well was marked on the UV transilluminator.
ろ紙にはさみ、 80ででー晚加熱 (ベ一キング (baking) ) した。  It was sandwiched between filter papers and heated with 80 (baking).
(4) D N Aハイブリ ダィゼ一シヨ ン  (4) D N A Hybridization
プレハイ ブリ ダィゼ一ショ ン用のプローブとしては、 5'— (TTAGGG) 4 - 3* (宝酒造製) を使用した。 このプローブを MEGALABELT M DNA 5'-End La bel ing ki t (宝酒造製) を用いて、 [ァ - 3 2 P ] ATP (Amersham製) で 5' 末端標識を行った。 標識したプローブは、 Chroma Spin- 10 Column (Clo n tech製) を用いて常法に従い逆相 HPLCで回収した。 The probe for Purehai yellowtail Dize one cane down, 5'(TTAGGG) 4 - was used 3 * (Takara Shuzo). The probes using MEGALABEL TM DNA 5'-End La bel ing ki t ( manufactured by Takara Shuzo), - was [§ 3 2 P] 5 'end labeled with ATP (manufactured by Amersham). The labeled probe was recovered by reverse-phase HPLC using a Chroma Spin-10 Column (manufactured by Clontech) according to a conventional method.
ベ一キングしたフィ ルタ一を 3 X SSCに浸した後に、 ハイ ブリ ダィゼー シヨ ンバッフ ァ一 ( I Xデンハル ト溶液、 1 M NaCK 50mM Tris -HCU 1 OmM EDTA, 0. 1 % SDS、 50 g/ mL変性サケ精子 D N Aを含む) に浸して、 65でで 3〜 4時間振盪し、 上記のプローブとともにプレハイプリ ダイゼ一 ショ ンを ί了った。 After soaking the baked filter in 3X SSC, the hybridization filter (IX Denhardt's solution, 1 M NaCK 50 mM Tris-HCU 1 OmM EDTA, 0.1% SDS, containing 50 g / mL denatured salmon sperm DNA), shaken at 65 for 3-4 hours, and completed prehybridization with the above probe.
プレハイ ブリ ダィゼーショ ンが終了 した後に、 シール ドバッ グにメ ン プレンフィ ル夕一を入れ、 標識プローブと 1 /z Lの変性サケ精子 DNA ( 10mg /mL) とを加えたハイ ブリ ダィゼ一シヨ ンバッ フ ァーを 2mL加えて、 泡が 入らないよう にシールした。  After the prehybridization is completed, put the sample filter in a shielded bag, and add the labeled probe and 1 / z L of denatured salmon sperm DNA (10 mg / mL) to the hybridization buffer. 2 mL was added and sealed to prevent bubbles from entering.
50 でー晚ィ ンキュベ一 ト し、 ハイプリ ダイゼーショ ンを行った。  Incubation was performed at 50, and hybridization was performed.
(5) 洗浄およびオー ト ラジオグラフィ ー  (5) Cleaning and autoradiography
ハイ ブリ ダィゼーシヨ ンを した後、 フィ ルターを洗浄バッ ファー ( 4 X SSC, 0. 1 % SDS) に浸し、 55 で 15分間振盪した。 この操作を 4回繰り返 した後に、 フィ ルターの水分をよ く切ってサランラ ップでく るみ、 増感 紙をつけたカセッ トに X緑フィ ルム (Sc ient i f ic Imaging Fi lm, Kodak 製) と ともにセッ ト して、 一 80でで一晚ォ一 ト ラジオグラフィ ーを行つ た。  After the hybridization, the filter was immersed in a washing buffer (4 × SSC, 0.1% SDS) and shaken at 55 for 15 minutes. After repeating this operation four times, the filter is well drained and covered with a Saran wrap. An X green film (Scientific Imaging Film, manufactured by Kodak) is placed in a cassette with an intensifying screen. ), And performed a default radiography at 180.
(6) データ解析  (6) Data analysis
現像したフィ ルムとフィ ルターの位置を合わせ、 マジッ クでゥエルの 位置を記入した。 T R Fはス メァ上に現れるので、 このスメァの濃さの ピークをデンシ ト メ ト リ 一 (Ul tra Scan XL Laser Densi tometer, Phar mac i a製) で検出 した。 ゥエルから ピークまでの距離を移動度とし、 その 移動度とマーカ一とで作成した検量線よ り、 T R Fの長さを求めた。  The position of the developed film and the filter was aligned, and the position of the jewel was marked by magic. Since the TRF appeared on the smear, the peak of the smear density was detected with a densitometer (Ultra Scan XL Laser Densitometer, manufactured by Pharmacia). The distance from the peak to the peak was defined as the mobility, and the length of the TRF was determined from a calibration curve created from the mobility and the marker.
(実施例 4) アルカ リ ホスフ ァターゼ (AP) 標識及び Z又はピオチン標識 プローブを用いた平均テロメァ長の測定 ( 1) 二本鎖合成オリ ゴヌク レオチ ドからなる リ ンカーおよび P C R用プ ライマーの合成 (Example 4) Measurement of average telomere length using alkaline phosphatase (AP) label and Z or biotin labeled probe (1) Synthesis of linkers composed of double-stranded synthetic oligonucleotides and primers for PCR
(1- 1) リ ンカ一の合成  (1-1) Synthesis of linker
平滑末端断片を得るために使用する二本鎖オリ ゴヌ ク レオチ ドからな る リ ンカ一 (配列番号 1及び 2) を D N Aシンセサイザー (Pharmacia Bio tech製) を用いて、 ホスホルアミ ダイ ト法によ り合成した。 すなわち、 反応基質であるアミダイ トをカラムに固定されたヌ ク レオチ ドの 3' 末端 に結合させ、 未反応基質を除去するとともに官能基をキヤ ッ ビングし、 酸処理して ト リ チル基をはずし、 ここに再びアミ ダイ 卜 を結合させ、 上 記の手順を繰り返して合成した。 アルカ リ処理によって合成したオリ ゴ ヌ ク レオチ ドをカ ラムから切り出し、 脱保護して、 逆相 HPLCによ り精製 し、 以下の実施例でリ ンカ一と して使用するオリ ゴヌ ク レオチ ドの画分 を分取した。  A linker consisting of a double-stranded oligonucleotide (SEQ ID NOS: 1 and 2) used to obtain a blunt-ended fragment was obtained by the phosphoramidite method using a DNA synthesizer (Pharmacia Biotech). Synthesized. That is, the amidite, which is a reaction substrate, is bound to the 3 'end of the nucleotide immobilized on the column, the unreacted substrate is removed, and the functional group is masked. After removal, the amidite was bonded again and the above procedure was repeated to synthesize. Oligonucleotides synthesized by the alkali treatment were excised from the column, deprotected, purified by reverse phase HPLC, and used as linkers in the following examples. Fractions were collected.
(1- 2) P C R用プライマ一の合成  (1-2) Synthesis of primer for PCR
P C Rで使用する TSプライマ一 (サブテロ メァ側プライ マ一、 配列番 号 3) および C Xプライマー (テロメァ側プライマー、 配列番号 4) を D N Aシンセサイザーによって作製した。  The TS primer (subtelomer primer, SEQ ID NO: 3) and CX primer (telomer primer, SEQ ID NO: 4) used in the PCR were prepared with a DNA synthesizer.
同様に合成した(TTAGGG) 4プローブを架橋剤 (bi funct ional reagent) であるホルムアルデヒ ドで処理し、 アルカ リ ホスファターゼ (AP) を化 学的に直接結合させて標識した。 この標識には、 AlkPhos Direct (Pharm acia製) を使用 した。 The (TTAGGG) 4 probe synthesized in the same manner was treated with formaldehyde as a cross-linking agent (bifunctional reagent), and labeled with alkaline phosphatase (AP) directly bound chemically. AlkPhos Direct (Pharmacia) was used for this labeling.
実施例 3 ( 1) で得た T R F を実施例 3 (2) に示すよう にァガロースゲ ル電気泳動して分画した。 マーカーには、 lkbの DNA ladder (BioRad製) を使用し た。 (2) T R Fの検出 The TRF obtained in Example 3 (1) was fractionated by agarose gel electrophoresis as shown in Example 3 (2). As a marker, a lkb DNA ladder (manufactured by BioRad) was used. (2) TRF detection
上記のよう に電気泳動したゲルを ト ラ ンスプロ ッタ一 (BioRad製) を 用いて、 ニ ト ロセルロースメ ンブランフィ ル夕一 (OPTITRAN BA-S、 Schl eic er Schuel製) に転写した。  The gel electrophoresed as described above was transferred to a nitrocellulose membrane filter (OPTITRAN BA-S, manufactured by Schleider Schuel) using a transplotter (BioRad).
このフィ ルターに、 0. 2 g/mLの上記のよ う に して得た AP標識プロ一 ブ、 も し く はピオチン標識プローブを結合させた。 ピオチン標識プロ一 ブは、 0. 3 g/mLのピオチン標識 dCTP (Pharmacia B i o t ech製)と dNTPとを 添加し、 0. 1 g/mLのク レノ ウ断片 (宝酒造製) で反応させた後、 制限酵 素 Smalで切断して得た。  To this filter, 0.2 g / mL of the AP-labeled probe or the biotin-labeled probe obtained as described above was bound. The biotin-labeled probe was prepared by adding 0.3 g / mL of biotin-labeled dCTP (Pharmacia Biotech) and dNTP and reacting with 0.1 g / mL of Klenow fragment (Takara Shuzo). Then, it was obtained by cutting with the restriction enzyme Smal.
ついで、 AP標識プローブの場合には、 CDP- Starと反応させて化学発光 を生じさせ、 ピオチン標識プローブの場合には、 0. 4 gZmLのス ト レブ トァビジン結合 HRP (ベ一リ ンガーマンハイム製) と 25*Cで 15分間結合さ せた。 この後に、 100 t Mの過酸化水素と 0. 8 g/niLのフルォレセイ ンーチ ラミ ド (NEN Li fe Science P roduc t s製)及び 又は 0. 3 g/mLの 1 , 4-ビシ ク ロ [ 2, 2. 2] オク タ ン (1, 4 - d i azobicyc lo [ 2, 2, 2] oc tane, DABCO) (モレキュラープローブ製) を添加して、 蛍光強度を増強させた。  Then, in the case of an AP-labeled probe, it reacts with CDP-Star to generate chemiluminescence, and in the case of a biotin-labeled probe, 0.4 gZmL of streptavidin-conjugated HRP (manufactured by Behringer Mannheim) And 25 * C for 15 minutes. This is followed by 100 tM of hydrogen peroxide and 0.8 g / niL of fluorescein starch (manufactured by NEN Life Science Products) and / or 0.3 g / mL of 1,4-bicyclo [2 , 2.2] octane (1, 4-diazobicyclo [2, 2, 2] octane, DABCO) (Molecular Probe) was added to enhance the fluorescence intensity.
この蛍光を CDP- Star (Pharmacia製) で検出した。  This fluorescence was detected by CDP-Star (Pharmacia).
(実施例 5) 放射性標識プローブを用いた平均テロメァ長の測定 (Example 5) Measurement of average telomere length using radiolabeled probe
( 1) 二本鎖オリ ゴヌ ク レオチ ドからなる リ ンカ一及び P C Rプライマ一 の合成  (1) Synthesis of linker and PCR primer consisting of double-stranded oligonucleotides
実施例 4の ( 1) と同様に して、 リ ンカ一 (配列番号 1及び 2) および P C R用プライマー (配列番号 3及び 4) を、 D N Aシンセサイザー (Pharm acia Biotech製) を用いて合成した。 (2) T R F平滑末端の取得 In the same manner as in (1) of Example 4, linkers (SEQ ID NOS: 1 and 2) and PCR primers (SEQ ID NOs: 3 and 4) were synthesized using a DNA synthesizer (Pharmacia Biotech). (2) Obtaining TRF blunt ends
実施例 1で得た皮膚表皮屑片から得られた D N Aを Hinf l (宝酒造製) を用いて 37 で 3〜4時間処理し、 付着末端と突出末端とを有する D N A 断片を得た。 上記 (1) で得た付着末端と突出末端とを有する D N A断片 (TRF) のサブテロメァ側に、 以下の配列  The DNA obtained from the skin epidermis debris obtained in Example 1 was treated with Hinfl (Takara Shuzo) at 37 for 3 to 4 hours to obtain a DNA fragment having cohesive ends and protruding ends. The following sequence is added to the subtelomere side of the DNA fragment (TRF) having the cohesive end and the protruding end obtained in (1) above.
5' AATCCGTCGAGCAGAGTTC 3'  5 'AATCCGTCGAGCAGAGTTC 3'
3' TTAGGCAGCTCGTCTCAAGTGA 5' (配列番号 1) を有する リ ンカ一 Sを結合させた (第 2 図参照) 。  Linker S having 3 ′ TTAGGCAGCTCGTCTCAAGTGA 5 ′ (SEQ ID NO: 1) was bound (see FIG. 2).
ついで、 このサブテロメァ側平滑末端化した T R Fのテロメァ側の 3'突 出末端に リ ンカ一 T (第 2 図参照) を咬ませた後、 D N Aポリ メ ラーゼ でェン ドフィ リ ングし、 下記のテロメァ側末端を有する T R F平滑末端 を得た。 このリ ンカ一 Tの中には、 後述する P C R増幅工程用のプライ マ一の塩基配列を含めておく。  Then, after ligation of linker T (see Fig. 2) to the 3 'protruding end of the telomeric side of the sub-telomere blunt-ended TRF, end-filling with DNA polymerase was performed. A TRF blunt end having a telomeric end was obtained. The linker T contains the base sequence of the primer for the PCR amplification step described later.
-GGTTAGGGTTAG 3'  -GGTTAGGGTTAG 3 '
- CCAATCCCAATC 5'  -CCAATCCCAATC 5 '
D N A Ligation Kit ver. 1 (宝酒造製) を用いて D N A連結させた。 両端を平滑末端化した T R Fサンプルをマイ ク ロチューブに入れ、 D N A Ligation Kit ver. 1 (宝酒造製) を用いて、 常法に従ってイ ンキュ ベーショ ン した後に、 このマイ ク ロチューブに等容のフエ ノ ールを加 え、 ついで、 4容の氷冷エタノールを加えて沈殿させ、 平滑末端断片を分 離した。  The DNA was ligated using DNA Ligation Kit ver. 1 (Takara Shuzo). A TRF sample having blunt ends at both ends is placed in a microtube, and is incubated using DNA Ligation Kit ver. 1 (Takara Shuzo) according to a conventional method. Then, 4 volumes of ice-cold ethanol was added for precipitation to separate blunt-ended fragments.
(3) 増幅  (3) Amplification
この平滑末端断片を铸型として、 実施例 4の (1一 2) で合成した TSブラ イマ一 (センスプライマー、 配列番号 3) と C Xプライマー (アンチセン スプライマ一、 配列番号 4) とを用いて、 サ一マルサイ ク ラ一 PC-800 (As tec製) にて、 以下の組成の P C Rミ ックス中で P C Rを行った。 Using this blunt-ended fragment as type I, the TS primer (sense primer, SEQ ID NO: 3) and the CX primer (antisense primer) synthesized in (112) of Example 4 were used. Using the primer and SEQ ID NO: 4), PCR was carried out in a PCR mixture having the following composition on a Thermal Cycler PC-800 (manufactured by Astec).
20mM Tris— HC1 (pH8. 3) 、 68mM KCU 1. 5mM MgCl 2 > ImM EGTA、 1. 0 5% Tween20, 5 g ITAS (テロメ ラーゼアツセィ内部標準品) 、 0. 1 u g TSプライマー (宝酒造製) 、 0.5 / M T4 gene 32 protein (Boehring er Mannheim) 、 50 M dNTPs、 2 U Taqポリ メ ラ一ゼ (宝酒造製) 、 4 Ci C α -3 2 P ] dCTP ( Ame r s h am製) 、 0. 1 g C Xプライマ一、 P C R 用 Wax (GIBCOZBRL製) を含む P C R用反応ミ ッ クスを調製した。 20 mM Tris-HC1 (pH 8.3), 68 mM KCU 1.5 mM MgCl 2 > ImM EGTA, 1.0 5% Tween 20, 5 g ITAS (telomerase Atsusei internal standard), 0.1 ug TS primer (Takara Shuzo), 0.5 / M T4 gene 32 protein ( Boehring er Mannheim), 50 M dNTPs, 2 U Taq poly ra one peptidase (Takara Shuzo), 4 Ci C α - 3 2 P] dCTP ( manufactured by Ame rsh am), 0. 1 g A PCR reaction mix containing CX primer and Wax for PCR (GIBCOZBRL) was prepared.
C Xプライマーはワ ッ クスによってチューブの底に隔離し、 その上に 他の成分を含む反応ミ ッ クスを重層した。 この反応ミ ッ クスの総容量は 8 0 Lと した。  The CX primer was isolated at the bottom of the tube by a wax, and the reaction mix containing other components was overlaid thereon. The total volume of this reaction mix was 80 L.
サ一マルサイ クラ一 PC- 800 (Astec製) を用いて、 94 40秒 /50 40秒/ U°C 50秒を 1サイ クルと して 32サイ クル、 P C Rを行った。  Using a thermal cycler PC-800 (manufactured by Astec), PCR was performed for 32 cycles, each cycle consisting of 94 40 sec / 50 40 sec / U ° C 50 sec.
(4) 増幅産物の泳動分離と検出  (4) Electrophoretic separation and detection of amplification products
(4- 1) 増幅産物の分離と検出  (4-1) Separation and detection of amplification products
上記 (3) で増幅した増幅産物を処理して、 皮膚由来の D N Aから得た T R Fをァガロースゲル電気泳動して分画した。 マーカーには、 lkbの D N A ladder (BioRad製) を使用した。  The amplification product amplified in (3) above was treated, and TRF obtained from skin-derived DNA was fractionated by agarose gel electrophoresis. As a marker, 1 kb DNA ladder (manufactured by BioRad) was used.
実施例 3で電気泳動したテロ メァ含有 D N A断片などをゲル ト ランスブ ロ ッタ一 (BioRad製) を用いて、 ニ ト ロセルロースメ ンブランフィ ルタ 一 (OPTITRANBA- S, Schleicher & Schuel製) に転写した。  The telomer-containing DNA fragment and the like electrophoresed in Example 3 were transferred to a nitrocellulose membrane filter (OPTITRANBA-S, manufactured by Schleicher & Schuel) using a gel trans- blotter (manufactured by BioRad).
このフィルターに、 0. の放射性標識プローブを結合させた。 The filter was bound with a radiolabeled probe of 0.
(4- 2) 平均テロメァ長の検出 (4-2) Detection of average telomere length
上記 (4— 1) のよう に して得られたエレク ト ロ フ ォ ログラムを、 デン シ トメ 卜 リー (NIH Image 1. 59) で解析して、 Molecular Imager (BioRa d製) に取り込み、 下記の式 (1) に従ってマスセンタ一を算出した。 The electropherogram obtained as described in (4-1) above is The analysis was performed with a history (NIH Image 1.59), incorporated into Molecular Imager (manufactured by BioRad), and the mass center was calculated according to the following equation (1).
MCa v = ∑ (MWj XFI ( ) /∑ (FI i ) …式 (1) MC av = ∑ (MWj XFI ( ) / ∑ (FI i)… Equation (1)
こ こで、 MCa vはマスセンターを表し、 MWは同時に電気泳動を行ったマ一 カー D N Aよ り求める D N A長である。 FIは蛍光強度を、 また、 I はバ ン ドの位置を表す。 In here, MC av represents the mass center, MW is a DNA length to determine Ri by Ma one car DNA was subjected to electrophoresis at the same time. FI represents the fluorescence intensity, and I represents the position of the band.
測定した、 頼骨頂部上、 眼よ り下でオ トガイ部よ り上の部位 (以下、 頓骨頂部上以外の顔の部分という) 、 および臀部の皮膚表皮屑片から得 られた D N Aの平均テロ メ ァ長を T R Fの平均値土標準偏差 (kb) と し て表 1 に示す。  The average of the DNA measured from the top of the metacarpal, below the eye and above the genitalia (hereinafter referred to as the face except the top of the abdomen), and from the dermis skin epidermis debris The telomere length is shown in Table 1 as the average value of TRF soil standard deviation (kb).
【表 1 】 被検者 一平均 TRF (テ Djtァ含有末端制限 DNA断片長 (平均土 SD (kb) )  [Table 1] Subject mean TRF (Djta-containing end-restricted DNA fragment length (mean soil SD (kb))
(歳) (n) 頰骨項部上 左記以外の顔の部分 臀部  (Years) (n) 上 Above the bone section Face parts other than those on the left Buttocks
20 - 24 24 10. 9±0. 7 1し 0± 1. 8 12. 6±0. 220-24 24 10.9 ± 0.7 1 1 0 ± 1.8 12.6 ± 0.2
31 - 38 15 8.0± 1.0 9. 1士 2. 5 11. 5土 0.331-38 15 8.0 ± 1.0 9.1 1st 2.5 11.5 Sat 0.3
48— 65 14 6. 2±2. 0 7. 3±3. 6 10. 3土 1. 1 表 1 から明らかなよう に、 いずれの部位の平均テロ メァ長も年齢が髙 く なるにつれて短く なつていた。 また、 頰骨頂部上の平均テロメァ長を 除き、 年齢に比例して平均テロ メァ長の標準備差 (SD) が大きく なつて いた。 さ らに、 頼骨頂部上の平均テロメァ長の短縮がもっ とも大きかつ たが、 SDの増加は小さかった。 また、 臀部のテロメァの短縮がもっ とも 緩慢であった。 さ ら に、 平均テロメァ長を見ると、 頰骨頂部上ぐ頰骨頂 部上以外の顔の部分ぐ臀部となっていた。 48—65 14 6.2 ± 2.0 0.3 ± 3.6 10.3 Sat 1.1 As can be seen from Table 1, the average telomere length of any part becomes shorter as the age increases. I was Except for the average telomere length on the 頰 bone apex, the standard deviation (SD) of the average telomere length increased in proportion to age. In addition, the reduction in mean telomere length on the apex of the tibia was the greatest, but the increase in SD was small. The shortening of the hip telomeres was the slowest. Looking further at the average telomere length, It was the buttocks of the face except for the top.
上記の結果よ り、  From the above results,
(1) 年齢とともに、 いずれの部位の皮膚のテロメァも短縮すること  (1) With age, shorten skin telomeres at any site
(2) 皮膚のテロ メァの短縮の程度は、 年齢が高く なるにつれて個人差が 大きくなること  (2) The degree of shortening of skin telomeres varies greatly with age as individuals age
(3) 顔のどの部分でも同様なテロメァの短縮を起こすのではないこと (3) Does not cause similar telomere shortening in any part of the face
(4) 頰骨頂部上ではテロメァ短縮のバラツキが少なく 、 特定の部位を選 択することで皮膚の老化度の良い指標とすることができること (4) テ ロ There is little variation in telomere shortening on the bone crest, and it can be used as a good index of skin aging by selecting a specific part.
(5) 平均テロメァ長の短縮の程度から、 臀部は光老化をあま り受けてい ないことが示唆されること  (5) The degree of shortening of the average telomere length suggests that the buttocks are less susceptible to photoaging.
(6) 臀部の平均テロメァ長は同一個人の加齢に伴う皮膚の老化度を計測 する場合の良好な基準にできること  (6) The average telomere length of the buttocks can be a good criterion for measuring the age of the skin with age of the same individual.
が明らかになった。 (実施例 6) 高比活性放射性標識プローブの作製 Was revealed. (Example 6) Production of high specific activity radiolabeled probe
(1) テロメァ検出用プローブとテンプレー トの作製  (1) Preparation of telomere detection probe and template
テロメァを以下のよう に作製した。 5' 末端標識をせず、 後の工程で制 限酵素によってテロ メァと切り離すことができる、 テロメァを D N A合 成するためのプライマー  Telomeres were prepared as follows. Primer for telomere DNA synthesis that can be cleaved from the telomere by a restriction enzyme at a later step without 5 'end labeling
5' CACGTGCTCGAGCCC 3' (配列番号 13)  5 'CACGTGCTCGAGCCC 3' (SEQ ID NO: 13)
を、 D NAシンセサイザ一 (Pharmacia Biotech製) で合成した。 Was synthesized using a DNA synthesizer (Pharmacia Biotech).
また、 テンプレー 卜  In addition, the template
3' GTGCACGAGCTCGGG(CCCAAT) 4 TCTAATCTGA 5' (配列番号 14) も上記プライマーと同様に合成した。 (2) テロメァ検出用プロ一ブの合成 3 ′ GTGCACGAGCTCGGG (CCCAAT) 4 TCTAATCTGA 5 ′ (SEQ ID NO: 14) was also synthesized in the same manner as the above primer. (2) Synthesis of probe for telomere detection
6.7mMの MgCl 2 と ImMの 2—メルカプトエタノールとを含有する 67mMのリ ン酸カ リ ウム緩衝液 (PH7.4) に、 20 Mの上記 (1) で合成したプライマ —及びテンプレー ト と、 5'— AGATTAGACT— 3'の配列を有するォリ ゴヌ ク レ ォチ ド、 33/i Mの [ α - 3 H ] dGTP、 22/z Mの [ α - 3 H ] dTTP、 及び I I u Mの [ c 一 3 H] dATPを、 大腸菌の D N Aポリ メラーゼ I の大断片である K lenow断片 (宝酒造製) 0.37ュニッ 卜 とを含む溶液 10/z L (pH7.4) 中で混 合し、 10でで 60分間反応させた。 5'— AGATTAGACT— 3'の配列を有するオリ ゴヌ ク レオチ ドで挟むことによって、 後の工程で使用するテロメァ検出 用標識プローブを P C R増幅する ことができる (第 4 図参照のこ と) 。 第 4図中、 13は配列番号 13のオリ ゴヌク レオチドを表し、 14は配列番号 1 4のオリ ゴヌ ク レオチ ドを表す。 また、 Smal及び Hindlllはそれぞれの制 限酵素の切断部位と、 これらの認識部位とを表す。 In 67 mM potassium phosphate buffer (PH7.4) containing 6.7 mM MgCl 2 and ImM 2-mercaptoethanol, 20 M of primer and template synthesized in the above (1) were added; O Li Gore j click Les O Chi de having the sequence 5'- AGATTAGACT- 3 ', of 33 / i M [α - 3 H] of dGTP, 22 / z M [α - 3 H] dTTP, and II u the [c one 3 H] dATP in the M, the solution 10 / z L (pH 7.4) mixed combined in containing K Lenow fragment (Takara Shuzo) 0.37 Yuni' Bok and a large fragment of DNA polymerase I of E. coli The reaction was performed at 10 for 60 minutes. By sandwiching between 5'-AGATTAGACT- 3'-oligonucleotides, the labeled probe for telomere detection used in the subsequent step can be PCR-amplified (see Fig. 4). In FIG. 4, 13 represents the oligonucleotide of SEQ ID NO: 13, and 14 represents the oligonucleotide of SEQ ID NO: 14. Also, Smal and Hindlll represent the restriction enzyme cleavage sites and their recognition sites.
この標識生成物を、 ゲルろ過カラムである Quick Spin Column Sephade x G- 25 (Boehr inger Mannheim製) と、 10mMの 卜 リ ス緩衝液 (pH8.0) - 20mMの KC1とを用いて精製した。  The labeled product was purified using a gel filtration column, Quick Spin Column Sephade x G-25 (manufactured by Boehringer Mannheim), and 10 mM tris buffer (pH 8.0) -20 mM KC1.
ついで、 10mMの ト リ ス緩衝液 (PH8.0) — 2 OmMの KC 1中で制限酵素 Sma I (宝酒造製) を 6ユニッ ト ZlOw Lに添加し、 30X:で 40分間反応させた。 この制限酵素消化物をさ らに、 Chroma Spin- 10カラム (Clontech製) と、 ポリ アク リルアミ ドゲル電気泳動とを用いて上記と同様に精製し、 さ らに制限酵素 Hindlll (宝酒造製) で D N A切断し、 この制限酵素消化 物を 7 Mの尿素存在下で同様に精製した。  Then, a restriction enzyme SmaI (manufactured by Takara Shuzo) was added to 10 mM Tris buffer (PH8.0) —2 OmM KC1 to 6 units of ZlOw L, and reacted at 30 ×: for 40 minutes. This digestion product was further purified using a Chroma Spin-10 column (Clontech) and polyacrylamide gel electrophoresis in the same manner as described above, and was further digested with the restriction enzyme Hindlll (Takara Shuzo). After digestion, the digestion product was purified in the same manner in the presence of 7 M urea.
このよう にして精製された放射性標識プロ一ブを、 液体シンチレーシ ョ ンカウンタ一で計測した結果、 2〜 7X 107 cpmZpmolという放射能の比 活性が得られた。 The radiolabeled probe purified in this way was measured by a liquid scintillation counter, and the radioactivity ratio was 2 to 7 × 10 7 cpmZpmol. Activity was obtained.
この値は、 従来の [ァ - 3 2 P ] dATPによる末端標識プローブの 1〜 3X 106 という比活性に比べて最低 6倍、 最高では 20倍以上となった。 したが つて、 この放射性標識プローブを用いる と、 ァガロースゲル電気泳動に 供する T R Fの量を従来のプローブを用いた場合の 1/6〜 1/20まで減少さ せる こ とができる。 このため、 顔の皮膚等、 特に痕跡を残さずに皮膚の 老化度を測定したい場合、 又はごく 少量の皮膚表皮屑片 しか得られない 場合等に有用である。 産業上の利用可能性 This value was at least 6 times, and at most 20 times more than the specific activity of 1-3 × 10 6 of the conventional end-labeled probe with [α- 32 P] dATP. Therefore, the use of this radiolabeled probe can reduce the amount of TRF to be subjected to agarose gel electrophoresis to 1/6 to 1/20 that of a conventional probe. Therefore, it is useful for measuring the degree of skin aging without leaving any trace, such as for facial skin, or when only a very small amount of skin epidermis is obtained. Industrial applicability
本発明の方法によれば、 少量の D N Aを用いて迅速かつ正確に、 皮膚 の老化度を測定する ことができる。  According to the method of the present invention, the degree of skin aging can be measured quickly and accurately using a small amount of DNA.
また、 本発明においては放射性標識を使用 しないか、 または少量の放 射性標識を使用する こ とによ り 、 迅速かつ安全に高感度で皮膚の老化度 を測定するこ とができる。  In addition, in the present invention, the use of a radioactive label or the use of a small amount of a radioactive label allows rapid, safe and highly sensitive measurement of skin aging.

Claims

請 求 の 範 囲 The scope of the claims
1 . 皮膚表皮屑片から抽出した D N Aを制限酵素処理して得た 1つの付 着末端とテロメァ特有 3'突出末端とを有する断片の両末端を末端修飾によ つて平滑末端断片とする工程と、 前記平滑末端断片の両端にリ ンカ一を 結合させた後に P C Rで増幅する工程と、 得られた少なく ともテロメァ 全配列を一部に含む増幅産物を泳動分離しその分布から平均テロメァ長 を標識プローブで検出する工程とを備える、 皮膚の老化度の測定方法。 1. A step in which both ends of a fragment having one attachment end and a telomere-specific 3 'protruding end obtained by treating DNA extracted from skin epidermal debris with a restriction enzyme into blunt-end fragments by terminal modification; A step of amplifying by PCR after binding a linker to both ends of the blunt-ended fragment, and electrophoretically separating the obtained amplification product containing at least a part of the entire telomere sequence and labeling the average telomere length from the distribution Detecting with a probe.
2 . 前記制限酵素が、 Hinfl、 MspI/HpalK および Rs a 1からなる群から 選ばれる制限酵素である こ とを特徴とする、 請求項 1 に記載の皮膚の老 化度の測定方法。  2. The method according to claim 1, wherein the restriction enzyme is a restriction enzyme selected from the group consisting of Hinfl, MspI / HpalK and Rsa1.
3 . 前記平滑末端断片が、 前記付着末端の一方と相補的な付着末端を 有する二本鎖オリ ゴヌ ク レオチ ドからなる リ ンカ一を前記付着末端と結 合させ、 かつ、 前記突出末端を有する断片の突出末端の 3'側から 6〜 24塩 基の配列に相補的な 5'- CCCTAA- 3'の反復配列を含む一本鎖ォリ ゴヌ ク レオ チ ド部分の 5'側に二本鎖の 3〜 12塩基対のオリ ゴヌ ク レオチ ドを連結さ せ、 これをプライマーと して D N Aポリ メ ラーゼで両端が平滑末端の二 本鎖オリ ゴヌ ク レオチ ドと して得られる こ とを特徴とする、 請求項 1 ま たは 2 に記載の皮膚の老化度の測定方法。  3. The blunt-ended fragment binds a linker consisting of a double-stranded oligonucleotide having a cohesive end complementary to one of the cohesive ends to the cohesive end, and From the 3 'end of the protruding end of the fragment having the 5'-CCCTAA-3' repeat sequence complementary to the 6-24 base sequence at the 5 'end of the single-stranded oligonucleotide moiety containing the 3'-repeated sequence A double-stranded 3 to 12 base pair oligonucleotide is ligated and used as a primer to obtain a double-stranded oligonucleotide with blunt ends at both ends using DNA polymerase. The method for measuring skin aging according to claim 1 or 2, wherein the skin aging degree is measured.
4 . 前記増幅工程で用いるセンスプライマーとアンチセンスプライマ —とが、 前記の二種の リ ンカーに各々含まれるヌ ク レオチ ド配列を有す る こ とを特徴とする、 請求項 1〜 3 のいずれかに記載の皮膚の老化度の 測定方法。  4. The method according to claim 1, wherein the sense primer and the antisense primer used in the amplification step have a nucleotide sequence contained in each of the two types of linkers. The method for measuring the degree of skin aging according to any one of the above.
5 . 皮膚表皮屑片から抽出 した D N Aを制限酵素処理して得たテロ ス ァ含有 D N A断片を、 放射性同位体、 蛍光化合物及び化学発光化合物か らなる群から選ばれる標識で標識されたテロメァ検出用標識プローブで 検出する皮膚の老化度の測定方法。 5. Telos obtained by treating DNA extracted from skin epidermal debris with restriction enzymes A method for measuring the degree of skin aging by detecting a DNA fragment containing a primer with a labeling probe for telomere detection, which is labeled with a label selected from the group consisting of radioisotopes, fluorescent compounds and chemiluminescent compounds.
6 . 前記標識プローブが、 標識プローブとしての 5'(TTAGGG) n 3' および/または 5'(TAACCC) n 3' (nは 3~5の整数を表す) と相補的な塩基配 列 と前記塩基配列に隣接する制限酵素認識配列とを有するテンプレー ト、 当該制限酵素認識配列を含むプライマー、 および [ a — 3H] dNTPを 少なく とも含有する基質に D N Aポリ メ ラ一ゼを作用させて反応産物を 得、 当該反応産物に当該制限酵素を作用させて得られる こ とを特徴とす る、 請求項 5に記載の皮膚の老化度の測定方法。 6. The labeled probe has a base sequence complementary to 5 ′ (TTAGGG) n 3 ′ and / or 5 ′ (TAACCC) n 3 ′ (n represents an integer of 3 to 5) as a labeled probe, and template and a restriction enzyme recognition sequence adjacent to a nucleotide sequence, a primer containing the restriction enzyme recognition sequence, and [a - 3 H] on substrates containing at least a dNTP by the action of DNA polymerase ra one peptidase reaction 6. The method for measuring the degree of skin aging according to claim 5, wherein the method is obtained by obtaining a product and reacting the reaction product with the restriction enzyme.
7 . 皮廣表皮屑片採取用器具と、 D N A抽出用溶液とを含むチューブ との少なく とも 2つを含み、 請求項 1 〜 6 のいずれかに記載の方法を実施 するための皮膚の老化度測定用キッ ト。  7. Degree of skin aging for carrying out the method according to any one of claims 1 to 6, comprising at least two of an instrument for collecting skin debris and a tube containing a solution for DNA extraction. Measurement kit.
8 . ソーンを植え込んだ様式の頭部と、 当該頭部と連結された把持部 とを含むラスプを皮膚表皮屑片採取用器具とする こ とを特徴とする、 請 求項 7 に記載の皮膚の老化度測定用キッ ト。  8. The skin according to claim 7, characterized in that a rasp including a head in which a thorn is implanted and a grip connected to the head is used as an instrument for collecting skin epidermis debris. Kit for measuring the degree of aging.
9 . 尖端が鋭角な繊維からなるソーンを縦横に植え込んだ頭部からな るラスプ。  9. A rasp consisting of a head with vertical and horizontal thorns made of fiber with sharp points.
1 0 . 把持部が、 頭部と分離できるよう に連結されている請求項 9記 載のラスプ。  10. The rasp according to claim 9, wherein the grip portion is connected so as to be separable from the head.
1 1 . 繊維径が 1 ~ 1 0 mである請求項 9又は 1 0記載のラスプ。 11. The rasp according to claim 9 or 10, wherein the fiber diameter is 1 to 10 m.
1 2 . 繊維の尖端角が 3 0 ° 以下である請求項 9 ~ 1 1 のいずれかに 記載のラスプ。 12. The rasp according to any one of claims 9 to 11, wherein the tip angle of the fiber is 30 ° or less.
PCT/JP1999/006711 1998-06-05 1999-11-30 Method for measuring the extent of skin aging and measurement kit WO2001040462A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP15777398A JP4013333B2 (en) 1998-06-05 1998-06-05 Method for measuring skin aging and measuring kit
PCT/JP1999/006711 WO2001040462A1 (en) 1998-06-05 1999-11-30 Method for measuring the extent of skin aging and measurement kit
AU14136/00A AU1413600A (en) 1999-11-30 1999-11-30 Method for measuring the extent of skin aging and measurement kit

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP15777398A JP4013333B2 (en) 1998-06-05 1998-06-05 Method for measuring skin aging and measuring kit
PCT/JP1999/006711 WO2001040462A1 (en) 1998-06-05 1999-11-30 Method for measuring the extent of skin aging and measurement kit

Publications (1)

Publication Number Publication Date
WO2001040462A1 true WO2001040462A1 (en) 2001-06-07

Family

ID=26440219

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP1999/006711 WO2001040462A1 (en) 1998-06-05 1999-11-30 Method for measuring the extent of skin aging and measurement kit

Country Status (2)

Country Link
JP (1) JP4013333B2 (en)
WO (1) WO2001040462A1 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7695904B2 (en) 2002-01-31 2010-04-13 University Of Utah Research Foundation Reducing non-target nucleic acid dependent amplifications: amplifying repetitive nucleic acid sequences
US9944978B2 (en) 2014-12-30 2018-04-17 Telomere Diagnostics, Inc. Multiplex quantitative PCR
US10227649B2 (en) 2003-01-24 2019-03-12 University Of Utah Research Foundation Methods of predicting mortality risk by determining telomere length
US10316366B2 (en) 2013-05-22 2019-06-11 Telomere Diagnostics, Inc. Measures of short telomere abundance
US10450602B2 (en) 2008-12-22 2019-10-22 University Of Utah Research Foundation Monochrome multiplex quantitative PCR

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4013333B2 (en) * 1998-06-05 2007-11-28 株式会社B&Cラボラトリーズ Method for measuring skin aging and measuring kit
WO2000061597A1 (en) * 1999-04-08 2000-10-19 Uab Research Foundation Antiproliferative activity of g-righ oligonucleotides and method of using same to bind to nucleolin
JP4526971B2 (en) * 2005-02-14 2010-08-18 株式会社資生堂 Evaluation method of skin aging condition using fibulin-5 as an index
CA2695414A1 (en) * 2007-08-10 2009-02-19 Tina Holding Aps Method for estimating telomere length
CN102618633A (en) * 2012-02-03 2012-08-01 常州亚当生物技术有限公司 Method for detecting length of the shortest telomere in cells by using improved STELA method

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5179992A (en) * 1975-01-07 1976-07-12 Canon Kk
WO1995013381A1 (en) * 1993-11-12 1995-05-18 Geron Corporation Telomerase activity assays
WO1996041016A1 (en) * 1995-06-07 1996-12-19 Geron Corporation Methods for measuring telomere length
JPH09206081A (en) * 1996-02-05 1997-08-12 Mitsubishi Chem Corp Measurement of human telomerase activity
JPH10215900A (en) * 1997-02-04 1998-08-18 Dai Ichi Seiyaku Co Ltd Measurement of enzyme activity
US5830644A (en) * 1992-05-13 1998-11-03 Geron Corporation Method for screening for agents which increase telomerase activity in a cell
JPH11346800A (en) * 1998-06-05 1999-12-21 Sony Cp Laboratories:Kk Measurement of aging degree of skin and measurement kit therefor

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5179992A (en) * 1975-01-07 1976-07-12 Canon Kk
US5830644A (en) * 1992-05-13 1998-11-03 Geron Corporation Method for screening for agents which increase telomerase activity in a cell
WO1995013381A1 (en) * 1993-11-12 1995-05-18 Geron Corporation Telomerase activity assays
WO1996041016A1 (en) * 1995-06-07 1996-12-19 Geron Corporation Methods for measuring telomere length
JPH09206081A (en) * 1996-02-05 1997-08-12 Mitsubishi Chem Corp Measurement of human telomerase activity
JPH10215900A (en) * 1997-02-04 1998-08-18 Dai Ichi Seiyaku Co Ltd Measurement of enzyme activity
JPH11346800A (en) * 1998-06-05 1999-12-21 Sony Cp Laboratories:Kk Measurement of aging degree of skin and measurement kit therefor

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7695904B2 (en) 2002-01-31 2010-04-13 University Of Utah Research Foundation Reducing non-target nucleic acid dependent amplifications: amplifying repetitive nucleic acid sequences
US10227649B2 (en) 2003-01-24 2019-03-12 University Of Utah Research Foundation Methods of predicting mortality risk by determining telomere length
US11193169B2 (en) 2003-01-24 2021-12-07 University Of Utah Research Foundation Methods of predicting mortality risk by determining telomere length
US10450602B2 (en) 2008-12-22 2019-10-22 University Of Utah Research Foundation Monochrome multiplex quantitative PCR
US11168359B2 (en) 2008-12-22 2021-11-09 University Of Utah Research Foundation Monochrome multiplex quantitative PCR
US10316366B2 (en) 2013-05-22 2019-06-11 Telomere Diagnostics, Inc. Measures of short telomere abundance
US9944978B2 (en) 2014-12-30 2018-04-17 Telomere Diagnostics, Inc. Multiplex quantitative PCR

Also Published As

Publication number Publication date
JP4013333B2 (en) 2007-11-28
JPH11346800A (en) 1999-12-21

Similar Documents

Publication Publication Date Title
Holland et al. Mitochondrial DNA sequence analysis of human skeletal remains: identification of remains from the Vietnam War
Gale et al. UV-induced formation of pyrimidine dimers in nucleosome core DNA is strongly modulated with a period of 10.3 bases.
Marenholz et al. Genetic analysis of the epidermal differentiation complex (EDC) on human chromosome 1q21: chromosomal orientation, new markers, and a 6-Mb YAC contig
Smith et al. A systematic approach to the sampling of dental DNA
EP0375408B1 (en) Method for making synthetic oligonucleotides which bind specifically to target sites on duplex DNA molecules, by forming a colinear triplex, the synthetic oligonucleotides and methods of use
Josefsson et al. Structure of a gene encoding the 1.7 S storage protein, napin, from Brassica napus.
Smith et al. SAS amplification in soft tissue sarcomas
Olopade et al. Construction of a 2.8-megabase yeast artificial chromosome contig and cloning of the human methylthioadenosine phosphorylase gene from the tumor suppressor region on 9p21.
WO2001040462A1 (en) Method for measuring the extent of skin aging and measurement kit
Garagna et al. Non-telomeric chromosome localization of (TTAGGG) n repeats in the genus Eulemur
Schmitt et al. Telomere length variation in normal and malignant human tissues
KR20010034814A (en) Quantitative Analysis of Gene Expression
Hossain et al. Modified guanidinium thiocyanate method for human sperm DNA isolation.
Herbert et al. Genotoxicity in fish embryos
ID27442A (en) OLIGONUKLEOTIDE FOR AMPLIFICATION AND DETECTION OF CORE ACRYLIC EPSTEIN BARR (EBV) CELLS
Emanuel et al. Amplification of specific gene products from human serum
Liu et al. XY sex reversal in the wood lemming is associated with deletion of Xp21–23 as revealed by chromosome microdissection and fluorescence in situ hybridization
CN103173544B (en) Mitochondrial T3866C detection kit of Leber disease, and application thereof
Kocova et al. Detection of Y chromosome sequences in a 45, X/46, XXq–patient by Southern blot analysis of PCR‐amplified DNA and fluorescent in situ hybridization (FISH)
Guerrini et al. Subtelomeric as well as telomeric sequences are lost from chromosomes in proliferating B lymphocytes
Fattorini et al. Sex identification by polymerase chain reaction of α‐satellite in aged tissue samples
Qin et al. Localization of human cardiac β-myosin heavy chain gene (MYH7) to chromosome 14q12 by in situ hybridization
Nekrutenko et al. Representational difference analysis to distinguish cryptic species
Sahashi et al. Increased mitochondrial DNA deletions in the skeletal muscle of myotonic dystrophy
Futaki et al. Relationship of the type of bcr-abl hybrid mRNA to clinical course and transforming activity in Philadelphia-positive chronic myelogenous leukemia

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU CA CN KR US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i
122 Ep: pct application non-entry in european phase